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• We estimate there are between 250,000 and 350,000 children 
of problem drug users in the UK – about one for every problem
drug user.
• Parental problem drug use can and does cause serious harm 
to children at every age from conception to adulthood.
• Reducing the harm to children from parental problem drug
use should become a main objective of policy and practice.
• Effective treatment of the parent can have major benefits for 
the child.
• By working together, services can take many practical steps to
protect and improve the health and well-being of affected children.
• The number of affected children is only likely to decrease when 
the number of problem drug users decreases.
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The Advisory Council on the Misuse of Drugs has a
statutory duty to advise the Government on drugs of misuse
and the health and social problems these may cause. Its
Prevention Working Group carries out in-depth Inquiries into
aspects of drug use that are causing particular concern, with
the aim of producing considered reports that will be helpful
to policy makers, service providers and others. Past topics
have included HIV and AIDS, Drug Misuse and the
Environment, and Reducing Drug-related Deaths. 
Twenty-five years ago, there were relatively few problem
drug users in the UK. Since then, the numbers have
increased dramatically, with no part of the country being
spared. For example, the number of known heroin addicts
and the number of heroin seizures increased 10-fold and
15-fold respectively between 1980 and the late 1990s.
In response, tackling problem drug use has become a high
priority for Government and the stimulus for enormous
service development in both statutory and voluntary sectors.
Equally, there were few children of problem drug users in
the late 1970s. Now, as our report will demonstrate, there
are several hundred thousand, yet they have received
relatively little attention. In 2000, the Council thus decided to
launch an Inquiry that would have the children of problem
drug users as its centre of attention.
Its terms of reference were to:
• estimate the number of children so affected in the UK;
• examine the immediate and long-term consequences of
parental drug use for these children from conception
through to adolescence;
• consider the current involvement of relevant health,
social care, education, criminal justice and other services;
• identify the best policy and practice here and abroad; and
• make policy and practice recommendations.
The effects of drugs are complex and vary enormously,
depending on both the drug and the user. While there
is probably no drug that is entirely harmless in all
circumstances, the Working Group accepts that not all drug
use is incompatible with being a good parent. Our Inquiry
has thus focused squarely on parental problem drug use and
its actual and potential effect on children. By problem drug
use we mean drug use with serious negative consequences
of a physical, psychological, social and interpersonal,
financial or legal nature for users and those around them.
Such drug use will usually be heavy, with features of
dependence. In the United Kingdom at present this typically
involves use of one or more of the following: heroin and
other opiates, benzodiazepines, cocaine or amphetamines.
Where drugs are injected, this poses a particularly serious
threat to users’ health and well-being and their relationships
with others. The consequences of problem drug use for the
user vary enormously from person to person and over time
– but they are often very serious. As will be seen, the
consequences for their children are also variable but often
very damaging. 
Throughout the report the term ‘parent’ is defined as
meaning a ‘person acting as a father, mother or guardian to
a child’. This role may be played by a variety of individuals
including the child’s natural mother or father, a step-parent,
a natural parent’s partner, a foster or adoptive parent, or a
relative or other person acting as a guardian or carer. In the
often unstable and unpredictable circumstances associated
with problem drug use, a child may have a succession of
parents or, sometimes, none. As the report will
demonstrate, it may be difficult to know who the parent is.
This is part of the problem.
The Working Group is well aware that problem drinking by
parents can have serious consequences for their children
and that there are probably at least as many children thus
affected as by problem drug use. Parental smoking is also
harming the health of many hundreds of thousands of
children in this country. However, it was decided that it was
beyond the scope of the Inquiry to do justice to these two
major topics. Our main focus is therefore on problem drug
use, with the impact of alcohol or tobacco being considered
as additional factors. Nevertheless, many of the
recommendations we make for protecting and supporting
the children of problem drug users will also be applicable to
the children of problem drinkers.
We have written this report with the aim of illuminating an
aspect of the harm caused by drug use that until now has
remained largely hidden. By highlighting both the size and
seriousness of the problem, we hope we can stimulate
vigorous efforts by both policy makers and service providers
to address the needs of some of this country’s most
vulnerable children.
Method of working 
The Working Group’s members are drawn from diverse
backgrounds and disciplines, predominantly in the fields of
drug use and children’s services (see Prevention Working
Group members and contributors). The Group had a total
of 15 all-day meetings between July 2000 and January
2003. It carried out extensive reviews of published research
and reports, commissioned analyses of existing data and
national surveys and took evidence from a wide range of
expert witnesses (see Prevention Working Group members
and contributors). A final draft was presented to a full
meeting of the Council in February 2003 and the report
was sent to Ministers in March 2003. 
Introduction
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Introduction 
The Inquiry has focused on the children in the UK with a
parent, parents or other guardian whose drug use has
serious negative consequences for themselves and those
around them.
Chapter 1 Estimates of the
scale of the problem
We sought to establish roughly how many children of
problem drug users there might be in the UK. We used
separate data sources and methods for England and
Wales and for Scotland. Data from Northern Ireland were
not available.
We estimate there are between 200,000 and 300,000
children in England and Wales where one or both parents
have serious drug problems. This represents about
2–3% of children under 16. Only 37% of fathers and
64% of mothers were still living with their children. The
more serious the drug problem, the less likely it was for
the parent still to be living with the child. Most children
not living with their natural parents were living with other
relatives: about 5% of all children were in care. 
We estimate there are between 41,000 and 59,000
children in Scotland with a problem drug using parent.
This represents about 4–6% of all children under 16.
Chapter 2 The impact of
parental problem drug use
on children
Problem drug use in the UK is characterised by the use
of multiple drugs, often by injection, and is strongly
associated with socio-economic deprivation and other
factors that may affect parenting capacity. It is typically
chaotic and unpredictable. Serious health and social
consequences are common. Parental problem drug use
can and often does compromise children’s health and
development at every stage from conception onwards.
Maternal drug use during pregnancy can seriously
affect fetal growth, but assessing the impact is usually
impossible, with multiple drugs being taken in various
doses against a background of other unfavourable
circumstances. There is serious concern about the effect
of cocaine on fetal development. Heroin and other
opiates, cocaine and benzodiazepines can all cause
severe neonatal withdrawal symptoms. The damaging
effects of tobacco and alcohol are well established, and
cannabis is not risk free. Maternal drug injecting carries
the risk of transmission to the baby of HIV and viral
hepatitis. Maternal nutrition may be poor.
After birth, the child may be exposed to many sustained
or intermittent hazards as a result of parental problem
drug use. These include poverty; physical and emotional
abuse or neglect; dangerously inadequate supervision;
other inappropriate parenting practices; intermittent or
permanent separation; inadequate accommodation and
frequent changes in residence; toxic substances in the
home; interrupted or otherwise unsatisfactory education
and socialisation; exposure to criminal or other
inappropriate adult behaviour; and social isolation.
They often interact with and exacerbate other parental
difficulties such as educational under-attainment and
mental health problems. 
The adverse consequences for children are typically
multiple and cumulative and will vary according to the
child’s stage of development. They include failure to
thrive; blood-borne virus infections; incomplete
immunisation and otherwise inadequate health care; a
wide range of emotional, cognitive, behavioural and other
psychological problems; early substance misuse and
offending behaviour; and poor educational attainment.
These can range greatly in severity and may often be
subtle and difficult to detect. 
Recommendations 
1. All drug treatment agencies should record an agreed
minimum consistent set of data about the children
of clients presenting to them.
2. Whether a client or patient has dependent children
and where they are living should be included as
standard elements in the National Drug Misuse
Treatment System in England and Wales and in the
Drug Misuse Databases in Scotland and Northern
Ireland and should be recorded in the same way to
allow comparisons between regions.
The risk of harm to the child may be reduced by effective
treatment and support for the affected parent(s) and by
other factors such as the presence of at least one other
consistent, caring adult; a stable home with adequate
financial resources; maintenance of family routines and
activities; and regular attendance at a supportive school. 
The complexity of the situation means it is not possible
to determine the precise effects on any individual child.
However, a large proportion of the children of problem
drug users are clearly being disadvantaged and damaged
in many ways and few will escape entirely unharmed.
Very little is known about the circumstances of many of
the children who no longer live with their natural parents.
By comparison with adult drug users, the children of
problem drug users have largely escaped the attention
of researchers. Whilst research in this area is extremely
difficult, it is important that high quality studies are
undertaken to help us better understand the impact of
parental problem drug use on children and to assess the
effectiveness of interventions designed to help them.
Chapter 3 The voices of
children and their parents
This chapter aims to shine more light on the lives of
children of problem drug users by drawing on interviews
with the children themselves and their parents. Their
testimony illustrates the all-pervasive nature of problem
drug use seeping into almost every aspect of their lives. 
Aspects highlighted include: the uncertainty and chaos
of family life dominated by drug use; children witnessing
their parents’ drug use, despite parental efforts to
conceal it; exposure to criminal activity such as drug
dealing, shoplifting and robbery; disruption of their
education; having to act as carers for their parents and
younger children; and living with the fear of public
censure and separation. 
The children described feelings of hurt, rejection, shame,
sadness and anger over their parents’ drug problems.
They often expressed a deep sense of absence and
isolation which was conveyed in the often used phrase
that their parents were not ‘there for them’. 
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Recommendations 
3. Problem drug or alcohol use by pregnant women
should be routinely recorded at the antenatal clinic
and these data linked to those on stillbirths,
congenital abnormalities in the newborn, and
subsequent developmental abnormalities in the child.
This would enable epidemiological studies to be
carried out to establish relationships between
maternal problem drug use and congenital and
developmental abnormalities in the child.
4. Studies should be urgently carried out to assess the
true incidence of transmission of hepatitis C between
infected female drug users and their babies during
pregnancy, birth and infancy.
5. A programme of research should be developed in the
UK to examine the impact of parental problem drug
use on children at all life stages from conception to
adolescence. It should include assessing the
circumstances of and consequences for both those
living with problem drug users and those living
elsewhere, and the evaluation of interventions aimed
at improving their health and well-being in both the
short and the long term.
Recommendations
6. The voices of the children of problem drug users
should be heard and listened to.
7. Work is required to develop means of enabling the
children of problem drug users safely to express their
thoughts and feelings about their circumstances.
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Chapter 4 Surveys of specialist
drug agencies, maternity units
and social work services
Questionnaires were sent to all maternity units and social
work services and to most specialist drug agencies in the
UK in early 2002. The aim was to learn more about
service provision for children of problem drug users and
their parents. The overall response rate was 55%. It is
likely that the agencies that did not respond would
generally have less service provision than those that did.
Specialist drug agencies
Seventy-five per cent of responding agencies had contact
with pregnant drug users. Only half reported that they
had services for pregnant drug users, half reported
offering services for clients who had dependent children,
and a third provided services specifically for the children
of drug misusing parents. Residential agencies were less
likely than community or out-patient agencies to offer
services for clients with children, services for pregnant
drug users and services for the children of drug users.
With pregnant drug users, over 80% of drug agencies
reported they would normally liaise with GPs, social work
services and maternity units. Two-thirds of the agencies
said they collected data on the number of clients’
children, but only a quarter could supply these data for
the previous year.
Maternity units
The responding units delivered an average of 2,400
babies a year of whom an estimated 1% were to problem
drug users and a similar number to problem drinkers.
82% reported an increase in the number of pregnant
problem drug users over the previous five years. 92%
reported their patients were routinely assessed for both
alcohol and drug use. 40% employed an obstetrician and
62% had midwives with a special interest in problem
drug use. 57% had specific protocols for the antenatal
management of drug users, 40% could offer substitute
prescribing to opiate-addicted pregnant women and 71%
had protocols for the management of withdrawal
symptoms in neonates. Most reported a high level of
liaison with appropriate services. 
Social work services
Responding agencies had an average of about 2,000
new cases of children in need and 143 cases on the child
protection register in the previous year. On average,
parental problem drug or alcohol use featured in a quarter
of cases of children on the child protection register.
Over 80% of agencies inquired about drug and alcohol
problems in the mother and father; 70% had specific
staff for dealing with substance use issues but only
40% had a protocol for decision-making for children
of substance users; 65% provided training in managing
families with substance use problems. 64% had formal
joint arrangements for working with other agencies in
child protection cases involving parental drug use. Only
43% reported providing specific services for problem
drug using parents and their dependent children. Liaison
with general practitioners was relatively infrequent.
Chapter 5 The legal framework
and child protection
arrangements
The Children Acts set out the responsibilities of local
authorities and other services for protecting children and
promoting their welfare. The key principle of the Acts is
that the well-being of the child is of paramount
importance. The Acts place a duty on agencies engaging
with problem drug users who have dependent children,
or directly with the children themselves, to assess the
needs of children if their health and well-being may be at
risk. The Acts state that parents should normally be
responsible for their children. This implies that public
authorities should not separate the child from the parent
unless it is clearly in the interests of the child to do so. 
Local authorities are under a duty to provide a range of
services to support children in need and their families.
Each local authority is required to have an Area Child
Protection Committee to promote, instigate and monitor
Recommendations
8. The Department of Health and the devolved executives
should ensure that all maternity units and social
service children and family teams routinely record
problem drug or alcohol use by a pregnant mother or
a child’s parents in a way that respects privacy and
confidentiality but both enables accurate assessment
of the individual or family and permits consistent
evaluation of and comparisons between services. 
9. The National Treatment Agency and the devolved
executives should ensure that all specialist drug and
alcohol services ask about and record the number, age
and whereabouts of all their clients’ children in a
consistent manner. 
joint policies in child protection work. Where a child is
considered at risk of serious harm, a Child Protection
Conference or, if parental cooperation is lacking, a court
or, in Scotland, a Children’s Panel hearing should lead to a
clear care plan being agreed and implemented. Provided
the child is not ‘at risk’, the local authority should not
invoke child protection procedures but should offer help
and support to enable parents to provide the necessary
care for their child at home. 
A recent review of 290 cases of childcare concerns in
London found that 34% involved parental drug or alcohol
misuse. They included many of the most severe cases of
abuse and neglect. Most of the social workers involved
were relatively newly qualified and had had little or no
training in working with drug or alcohol misuse.
The Child Protection Review in Scotland found that
parental drug or alcohol misuse was involved in 40% of
cases. It highlighted the particular challenges this created
and called for changes to the child protection system and
increased resources for childcare services.
The Laming Report has highlighted serious failings in the
child protection arrangements in England and has
recommended sweeping reforms. However, it did not
address the issue of parental problem drug use.
Chapter 6 Recent relevant
developments in Government
strategies, policies and
programmes
A wide range of recent Government initiatives aimed at
tackling drug use or helping children have the potential to
benefit children of problem drug users.
England
The Updated Drug Strategy for England (2002) is wide-
ranging and ambitious but devotes little attention to the
children of problem drug users. The National Treatment
Agency for Substance Misuse has developed models of
care that require drug and alcohol services to recognise
the need to support clients’ children. It also requires staff
to be able to assess the effect of substance misuse on
the family and requires services to collect data on clients’
children. The Children’s National Service Framework, the
Green Paper on Children at Risk, Extended Schools and
Sure Start are examples of major initiatives designed to
improve the health and well-being of children.
Wales
The Welsh Substance Misuse Strategy (2000) includes
supporting the children of problem substance misusers
as an important objective but does not describe specific
initiatives. The Framework for Partnership, the Children
and Youth Support Fund and the Children’s National
Service Framework and the Children’s Commissioner for
Wales are examples of initiatives aimed at enhancing the
lives of children. 
Scotland
The Drugs Action Plan: Protecting Our Future (2000)
identifies the children of drug misusing parents as a
priority group. Good practice guidance for working with
children and families affected by substance misuse were
published in 2003. All Drug Action Teams and Area Child
Protection Committees are now required to have in place
local policies on support to drug misusing parents and
their children in line with national guidance.
For Scotland’s Children: Better Integrated Children’s
Services (2001) highlights the major impact of parental
problem drug use on children and stresses that helping
children with drug misusing parents is a task for health
and education and social services. Sure Start Scotland,
Social Inclusion Partnerships and Starting Well are all
initiatives designed to improve the well-being of children
in disadvantaged areas. The Changing Children’s Services
Fund is partly earmarked for initiatives designed to help
the children of problem drug users.
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Recommendation 
10. When revising child protection policies and
procedures, full account should be taken of the
particular challenges posed by parental problem drug
use, with the consequent implications for staff training,
assessment and case management procedures, and
inter-agency liaison.
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Chapter 7 The practicalities of
protecting and supporting the
children of problem drug users
Access to and coordination of services 
All children have a right of access to the universal
services of health care and education. There are also
specific services for families, children and problem drug
users that have the potential to benefit the children of
problem drug users. Drug Action Teams or the equivalent
bodies have the responsibility for coordinating the local
response to drug use. Relatively few have as yet focused
their attention on the children of problem drug users.
If the complexities of the needs of children of problem
drug users are to be addressed, agencies must work in
partnership across organisational and professional
boundaries.
Services working with problem drug users should: see the
well-being of the child as being of paramount importance;
be accessible, welcoming and non-stigmatising to problem
drug users who have children; and be able to share
information with other agencies and professionals on a
‘need to know’ basis when it is in the interests of the
child to do so.
Maternity services
Accessible and welcoming maternity services are as
important to a pregnant problem drug user as to any
other woman. The best services offer a comprehensive
and integrated approach to both the health and social
care issues surrounding the pregnancy and involve the
woman in the decision-making process as much as
possible.
Maternity unit staff need appropriate training to provide
them with sufficient knowledge of drug use and its
consequences for the pregnancy and the future child,
and an understanding of what can be done to achieve
the best outcome for mother and baby. Multi-disciplinary
assessments and forward planning are an essential
foundation for sensible, timely decision-making and
the provision of helpful support for the mother and
new-born child.
Recommendations 
11. Reducing the harm to children as a result of parental
drug use should be a main objective of the UK’s
drug strategies. 
12. The Government should ensure that the National
Children’s Service Framework and equivalent
strategic arrangements in Wales, Scotland and
Northern Ireland, identify children of problem drug
users as a large group with special needs that
require specific actions by health, education and
social services.
13. The National Treatment Agency, the Welsh
Assembly Government and the Scottish Executive
should ensure that services for adult substance
misusers identify and record the existence of clients’
dependent children and contribute actively to
meeting their needs either directly or through
referral to or liaison with other appropriate services,
including those in the non-statutory sector.
This should include protocols that set out
arrangements between drug and alcohol services
and child protection services.
14. Whenever possible, the relevant Government
departments should ensure there are mechanisms
in place to evaluate the extent to which the many
initiatives outlined in this chapter benefit vulnerable
children, including the children of problem drug
users.
Recommendations
15. All Drug Action Teams or equivalent bodies should
ensure that safeguarding and promoting the interests
of the children of problem drug users is an essential
part of their area strategy for reducing drug-related
harm and that this is translated into effective,
integrated, multi-agency service provision.
16. All Drug Action Teams or equivalent bodies should
have cross-representation with the relevant children’s
services planning teams in their area.
17. Drug misuse services, maternity services and children’s
health and social care services in each area should
forge links that will enable them to respond in a
co-ordinated way to the needs of the children of
problem drug users.
Primary care
Although the management of problem drug users by
general practitioners remains contentious, there are
numerous examples of primary care teams providing a
high standard of care for problem drug users. A focus on
their children appears much less common. 
Registration of the child with a GP is an essential first
step but may be prevented by various factors including
professional attitudes to drug use and the chaotic lifestyle
and frequent changes of address of some problem drug
users. 
The ideal situation is where the child is registered with a
primary care team who are both committed to providing
comprehensive health care for problem drug users and
able to recognise and meet the health needs of their
children.
Contraception and planned pregnancy
Most services in contact with problem drug users pay
scant attention to contraception and the prevention of
unwanted pregnancy. Many female problem drug users
are able to make sensible decisions about pregnancy and
take effective contraceptive measures if they have
access to a sympathetic service. Long-acting injectable
contraceptives, the progestogen coil and contraceptive
implants have major advantages over the contraceptive
pill and the condom when compliance is unlikely.
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Recommendations 
18. Every maternity unit should ensure that it provides
a service that is accessible to and non-judgemental
of pregnant problem drug users and able to offer
high quality care aimed at minimising the impact
of the mother’s drug use on the pregnancy and the
baby. This should include the use of clear
evidence-based protocols that describe the clinical
management of drug misuse during pregnancy and
neonatal withdrawals.
19. Pregnant female drug users should be routinely
tested, with their informed consent, for HIV, hepatitis
B and hepatitis C, and appropriate clinical
management provided including hepatitis B
immunisation for all babies of drug injectors.
20. Every maternity unit should have effective links with
primary health care, social work children and family
teams and addiction services that can enable it to
contribute to safeguarding the longer-term interests
of the baby.
Recommendations
21. Primary Care Trusts or the equivalent health authorities
in Wales, Scotland and Northern Ireland should have
clear arrangements for ensuring that the children of
problem drug or alcohol users in their area are able to
benefit fully from appropriate services including those
for the prevention, diagnosis and treatment of blood-
borne virus infections.
22. Primary care teams providing services for problem drug
users should ensure that the health and well-being of
their children are also being met, in partnership with the
school health service, children and family teams and
other services as appropriate.
23. Training programmes on the management of problem
drug use by primary care staff should include
information about the importance of recognising and
meeting the health care needs of the children of
problem drug users.
Recommendations
24. All general practitioners who have problem drug users
as patients should take steps to ensure they have
access to appropriate contraceptive and family
planning advice and management. This should include
information about and access to emergency
contraception and termination of pregnancy services.
25. Contraceptive services should be provided through
specialist drug agencies including methadone clinics
and needle exchanges. Preferably these should be
linked to specialist family planning services able to
advise on and administer long-acting injectable
contraceptives, contraceptive coils and implants. 
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Early years education and schools
School can be a safe haven for the children of problem
drug users, the only place where there is a pattern and a
structure in their lives. Schools and their staff can do
much to help these children but need to be supported by
and liaise with other agencies and initiatives that have
complementary resources and expertise. 
Social work children and family
services
Every local authority area social services department has
a children and family service with responsibility for child
protection and childcare. For every child referred to the
service, a systematic assessment is an essential first
step to establish whether he or she is in need or at risk
and, if so, how. This should include standard questions
about parental substance misuse. The child’s own
perception of the situation should be sought and recorded
whenever possible. If it is decided the child can remain at
home, plans will be required to mobilise support for the
family in an attempt to safeguard the child’s welfare.
Support for parents and the extended family could include
treatment of the parent’s problem drug use; advice and
support on parenting skills; and help in improving
accommodation or accessing benefits. Support for
children themselves could include: allowing them to
express their own ideas and feelings; enabling them to
have fun; arranging attendance at nursery; providing
special educational support; providing access to health
care and other services; and arranging assessment and
treatment of emotional and behavioural problems. 
Fostering, residential care and adoption 
Fostering, residential care and adoption are the main
options when it is judged unsafe for a child to remain
with his or her parents. We could not establish the
Recommendations 
26. All early years education services and schools
should have critical incident plans and clear
arrangements for liaison with their local social
services team and area child protection committee
when concerns arise about the impact on a child of
parental problem drug or alcohol use. 
27. All schools should identify at least one trained
designated person able to deal with the problems
that might arise with the children of problem drug
users.
28. Gaining a broad understanding of the impact of
parental problem drug or alcohol use on children
should be an objective of general teacher training
and continuous professional development.
Recommendations
29. All social services departments should aim to achieve
the following in their work with the children of problem
drug users:
• An integrated approach, based on a common
assessment framework, by professionals on the
ground including social workers, health visitors and
GPs, nursery staff and teachers, child and adolescent
mental health services.
• Adequate staffing of children and family services in
relation to assessed need.
• Appropriate training of children and family service staff
in relation to problem drug and alcohol use.
• A co-ordinated range of resources capable of providing
real support to families with drug problems, directed
both at assisting parents and protecting and helping
children.
• Sufficient provision of foster care and respite care
suitable for children of problem drug users when their
remaining at home is unsafe.
• Efficient arrangements for adoption when this is
considered the best option.
• Residential care facilities that provide a genuinely
caring environment for those children for whom this
is the only realistic option.
30. The Government should continue to explore all
practical avenues for attracting and retaining staff
in the field of child protection.
31. The new Social Care Councils for England, Wales,
Scotland and Northern Ireland should ensure that all
social care workers receive pre-qualification and
in-service training that addresses the potential harm
to children of parental substance misuse and what
practical steps can be taken to reduce it. Consideration
should be given to the inclusion of such training as a
prerequisite for registration by the appropriate
professional bodies.
number of children who are in care as a result of parental
problem drug or alcohol misuse. A comprehensive and
careful assessment of the child’s needs and the home
and parental circumstances is essential for good decision-
making. Delays in reaching decisions about adoption can
be detrimental to the child, particularly when the child is
very young and developmental problems can quickly
develop. Where parental problem drug use is involved,
it is important to be realistic about the prospects of
rehabilitation. Fostering offers the greatest potential for
development. There is a need to increase both the
flexibility of arrangements and the intensity of the support
that can be offered to foster parents, with education and
training about drug misuse provided where relevant. 
Specialist drug and alcohol services
Because they are often the main agency in contact with
problem drug-using parents, all drug agencies should
contribute to assessing and meeting the needs of their
clients’ children. This should be seen as an integral part
of reducing drug-related harm. Services should thus aim
to become family friendly with an emphasis on meeting
the needs of women and children. 
Gathering basic information about clients’ children is an
essential first step. Thereafter, drug agencies should
concentrate upon a number of key tasks. These should
include: reducing and stabilising the parent’s drug use as
far as possible; discussing safety at home; liaising with the
family’s health visitor; ensuring the child is registered with
a GP and is immunised; checking the child receives early
years and school education; and liaising with the local child
protection team if harm to the child is suspected.
Specialist paediatric and child and
adolescent mental health services
Where child abuse or neglect is suspected by paediatric
or casualty staff, evidence for parental substance misuse
should be routinely sought. Parental substance misuse
should also always be considered by child and adolescent
mental health services. Staff will thus require appropriate
training.
Specialist children’s charities and other
non-statutory organisations
There are many non-statutory organisations working to
support children in need. Few are currently providing
services specifically aimed at helping the children of
problem drug users. There is considerable scope for
developing a major contribution in the future, ideally
in partnership with the statutory agencies.
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Recommendations 
32. Residential care for the children of problem drug users
should be considered as the option of last resort.
33. The range of options for supporting the children of
problem drug users should be broadened to include:
day fostering; the provision of appropriate
education, training and support for foster parents;
and robust arrangements to enable suitable willing
relatives to obtain formal status as foster parents. 
34. Where fostering or adoption of a child of problem
drug users is being seriously considered, the
responsible authorities should recognise the need
for rapid evidence-based decision-making,
particularly in the case of very young children
whose development may be irreparably
compromised over a short period of time. 
Recommendations
35. Drug and alcohol agencies should recognise that they
have a responsibility towards the dependent children of
their clients and aim to provide accessible and effective
support for parents and their children, either directly or
through good links with other relevant services.
36. The training of staff in drug and alcohol agencies should
include a specific focus on learning how to assess and
meet the needs of clients as parents and their children.
Recommendations
37. The possible role of parental drug or alcohol misuse
should be explored in all cases of suspected child
neglect, sexual abuse, non-accidental injury or
accidental drug overdose.
38. Child and adolescent mental health services should
routinely explore the possibility of parental drug or
alcohol misuse.
39. Acquiring the ability to explore parental substance
misuse should be a routine part of training for
professionals working in child and adolescent mental
health services.
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Police
Many problem drug users have frequent contact with the
police. The children of problem drug users can be given up
to 72 hours ‘police protection’ if they are at immediate risk.
The need to report children coming to the notice of police
in non-urgent circumstances is vital, and is an obligation
which needs continual reinforcement with police officers.
Courts and prisons
Courts need to ensure that satisfactory care arrangements
are made when a custodial sentence for a woman with
children is being considered. Drug Courts and Drug
Treatment and Testing Orders offer scope for community
sentencing for problem drug users with children. A large
proportion of women in prison are problem drug users and
probably at least half have children. Data on the number of
pregnant women in prison are not available. Four English
prisons have a mother and baby unit, enabling babies to
remain with their mothers until they are up to 18 months
old. Scotland’s only women’s prison enables babies to
remain with their mothers when considered appropriate.
Planning and organising post-release aftercare for women
problem drug users who have custody of their children
can be complex but is essential.
Chapter 8 Conclusions
Both the number of children affected and how they are
affected by parental problem drug use may come as a
surprise to many. Future numbers and their needs will
reflect changes in the extent and patterns of drug use
across the UK. Given its association with violent
behaviour, the recent increase in the use of crack
cocaine in some areas is especially troubling.
With greater recognition of these children’s needs should
come a determination to act. Effective treatment and
support for their parents can help greatly but will often
not be enough. Children deserve to be helped as
individuals in their own right. Many services have a part
to play: can they now rise to the challenge? Better
training and more or redeployed resources are likely to
be part of the answer, but, as a number of agencies
have shown, it is imperative to seize policy and practice
opportunities. Where there is a will there is a way.
Recommendations 
40. Given the size and seriousness of the problem, all
non-statutory organisations dedicated to helping
children or problem drug or alcohol users should
carefully consider whether they could help meet the
needs of the children of problem drug or alcohol users.
41. Drug Action Teams should explore the potential of
involving non-statutory organisations, in conjunction
with health and social services, in joint work aimed at
collectively meeting the needs of the children of
problem drug or alcohol users in their area.
42. Agencies committed to helping the children of
problem drug or alcohol users should form a
national association to help catalyse the
development of this important area of work.
Recommendation 
43. Every police force in the country should seek to
develop a multi-agency abuse prevention strategy
which incorporates measures to safeguard the
children of problem drug users.
Recommendations
44. When custody of a female problem drug user is being
considered, court services should ensure that the
decision fully takes into account the safety and well-
being of any dependent children she may have. This
may have training implications for sentencers.
45. The potential of Drug Courts and Drug Treatment and
Testing Orders to provide non-custodial sentences for
problem drug users with children should be explored.
46. All women’s prisons should ensure they have facilities
that enable pregnant female drug users to receive
antenatal care and treatment of drug dependence of the
same standard that would be expected in the community.
47. All female prisoners should have access to a suitable
environment for visits by their children. In addition,
where it is considered to be in the infant’s best
interests to remain with his or her mother,
consideration should be given by the prison to
allowing the infant to do so in a mother and baby unit
or other suitable accommodation. 
48. Women’s prisons should ensure they have effective
aftercare arrangements to enable appropriate support
to be provided after release for female problem drug
users with children.
Chapter 1
Estimates of the scale of the problem
Aims of the chapter
1.1 An essential part of our Inquiry is to gain the best
understanding we can of how many children are affected
by parental drug use in the UK. The aims of this chapter
are thus to: 
• establish the proportion of problem drug users who
have dependent children and whether these children
are living with their parent(s); 
• compare parents with non-parents, and those living
with their children with those who do not, according
to their characteristics, the features of their drug use
and potential risk factors for children; 
• provide a rough estimate of the number of children
of problem drug users across the UK. 
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Key findings
Parents among problem drug users
accessing treatment in England and
Wales
1. A five-year dataset from English and Welsh drug
misuse treatment services had information on over
300,000 problem drug users accessing treatment
during 1996–2000. There were parenthood data on
221,000 (71%) of whom 95,000 (43%) had dependent
children, including 53% of the women and 40% of the
men. 
2. Of those with dependent children, 69% were fathers
and 31% were mothers, both with an average of just
over two children each. This represents just under
one dependent child (under 16 years) for every
problem drug user accessing treatment.
3. The annual number of both parents and non-parents
using services more than doubled in the study period. 
4. The proportion of service users with dependent
children increased from 39% to 45% over the
five-year period. 
5. Only 46% had their children living with them; 54%
had children living elsewhere (usually with other
family members or friends) including 9% whose
children were in care. The proportion of parents not
living with their children increased from 51% in 1996
to 57% in 2000.
6. Mothers were far more likely (64%) than fathers
(37%) to live with their children.
7. Seventeen per cent of all the 15–19-year-olds and 22%
of the female 15–19-year-olds had dependent children. 
Relationships between parenthood and
risk factors
8. Non-parents and parents living with their children had
on average a lower number of risk factors than
parents whose children lived elsewhere. Parents living
with their children were the least likely to be sharing
injecting equipment, to be using stimulants regularly
or to have unstable accommodation. However, many
still had multiple problems. 
9. The likelihood that parents would be living with their
children steadily diminished as the number of risk
indicators increased. Of those with no risk factors,
65% lived with their children, compared with 28%
with three risk factors and only 9% with six or more. 
Estimates of numbers of children of
problem drug users in England and
Wales 
10.Using two different but related methods, we estimate
there are 200,000–300,000 children of problem drug
users in England and Wales. This represents 2–3%
of all children under 16.
Estimates of numbers of children of
problem drug users in Scotland
11.Combining data from three separate data sources, we
estimate there are 41,000–59,000 children of problem
drug users in Scotland. This represents 4–6% of all
children under 16.
12.There are an estimated 10,000–19,000 children in
Scotland living with a problem drug-using parent.
Sources of data
1.2 As set out in the Introduction, the focus of this
Inquiry is on the children of problem drug users. We have
defined problem drug use as drug use with serious
negative consequences of a physical, psychological,
social and interpersonal, financial or legal nature for users
and those around them. Most of the data we have about
problem drug users in the UK are collected by agencies
providing them with treatment and support. Until 2001,
this included data about dependent children. Thus, the
most useful source of information about the number of
children of problem drug users are the data recorded by
treatment services. 
1.3 For over 10 years, treatment services for problem
drug users in England and Wales have routinely recorded
a minimum data set about new clients presenting for
treatment1, 2. These data have been anonymised and then
collected by 12 regional Drug Misuse Databases (DMDs)
where they are checked (to avoid double counting and
other errors) and analysed3. Until the end of 2000,
recorded information included social circumstances such
as employment, housing, legal situation and dependent
children, a detailed drug profile including indication of
severity and risk, and service response data. Following a
strategic review by the Department of Health, the system
in England and Wales was replaced in 2001 by the
National Drug Treatment Monitoring System (NDTMS).
Since then, information about dependent children has not
been collected. A similar database exists in Scotland and
has remained more or less unchanged since its
introduction. However, this records less information about
dependent children. In Scotland, we have also been able
to draw upon recent estimates of the prevalence of
problem drug use and a follow-up study of problem drug
users accessing treatment. As the Scottish data are not
directly comparable with the English and Welsh data,
they have been analysed separately. Northern Ireland has
only recently set up a drug misuse database and this
does not record data about clients’ children.
1.4 Our sources of information are limited because they
only relate to those problem drug users who have
accessed treatment and they are not uniformly recorded
throughout the UK. Despite this, they have given us an
unprecedented opportunity to quantify the number of
children of problem drug users across the country. To our
knowledge, this has not previously been done anywhere
in the world.
England and Wales
1.5 The full data set for the five years 1996–2000 was
obtained from 11 of the 12 regional database centres in
England and Wales. Data from the South West of
England were not available due to technical problems.
The figures presented here are likely to be a 11%
underestimate, as this is the average proportion of
records contributed by the South West database over
the five-year period. To avoid double counting, only one
presentation by each individual in any one year was
included. Individuals starting treatment episodes in
different years were included in each year (18% of users
were represented in subsequent years) for the analysis of
trends and in order to reflect changes in personal
circumstances, especially with regard to children.
Analyses were re-run excluding repeaters to ensure that
exclusion of double counting between years would not
have yielded different findings.
Dependent children
1.6 Children are defined as ‘dependent’ if under the age
of 16, and are usually, but not always, considered to be
dependent on the person(s) under whose care they are.
Confusion may arise especially where the client is the
natural parent of a child or children but is no longer living
with them or is living with a child or children belonging to
someone else. As children are more likely to live with
their mothers, fathers may be less likely to declare their
children, whom they may not consider to be dependent.
Information was recorded about the number of
dependent children living at home, elsewhere, in care,
or whose residence was ‘unspecified’ (ie where it was
known that clients had children but not where they lived). 
Missing data
1.7 Drug use and parenthood is a very sensitive issue.
Not all drug services ask about children at assessment,
and not all drug users may be prepared to give
information about children early on in treatment (for
example, for fear of official intervention). Consequently,
the levels of missing data on the proportion of clients
who are parents is considerable, with 29% of records
having no information on parenthood. Two other factors
should also be borne in mind: a small number of non-
participant drug treatment services do not report to the
national system and some participant services do not
report everyone. The overall effect of these factors is that
the figures are an underestimate of the total population
presenting for treatment. 
Sample description
1.8 The five-year data set contained information on
313,169 problem drug users. The average age of drug
users accessing services was 29 years. Twenty-six per
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cent of users were female, a male-female ratio of 2.9:1.
Parenthood data were available for 221,124 (71%)
individuals. Of these, 95,143 (43%) reported having
dependent children. The number of both parents and
non-parents accessing services year-on-year more than
doubled in the study period. The proportion of users with
dependent children increased from 39% to 45% over the
five-year period, a trend that remains even if double
counting across years is removed (Table 1.1). Possible
reasons for this include an increased willingness to
disclose information about parenthood to agencies or a
real increase in the proportion of users with dependent
children. Fifty-three per cent of women reported having
children compared with 40% of men (Table 1.2). 
1.9 The 92,045 (29%) for whom parenthood data were
not available were not thought to be significantly different
from those for whom data were available. The average
ages were virtually identical (28.7 vs 28.9), although there
were more females in the former group (25.7%) than in
the latter (23.2%). This is presumably a function of there
being more mothers living with their dependent children
(and therefore more likely to declare) than fathers.
1.10 Not unexpectedly, parents were on average older
(30.7 years) than non-parents (27.6 years), and mothers
younger (30.3 years) than fathers (31.4 years) (Figure 1.1).
An important finding was that 17% of all 15–19-year-olds,
including 22% of females, reported having dependent
children, as did 6% of under 15-year-olds. 
1.11 Parents and non-parents did not differ much in their
social profiles (Table1.3). Both groups were
overwhelmingly white. A larger proportion of parents
lived in private or council rented accommodation (70% vs
56%), whereas non-parents were more likely to own their
home (23% vs 16%). Non-parents were also slightly
more likely to live in unstable or other accommodation.
Figure 1.1: Proportion of parents in each age group
by gender
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Table 1.1: Number and percentage of problem drug-using parents
1996 1997 1998 1999 2000 All years
Parents 10,577 13,850 19,759 23,422 27,535 95,143
% parents 39 42 44 42 45 43
Non-parents 16,450 18,898 25,441 31,762 33,430 125,981
Total 27,027 32,748 45,200 55,184 60,965 221,124
Table 1.2: Parenthood by gender
All years %
Women Parents 29,996 53
Non-parents 26,780 47
Men Parents 65,147 40
Non-parents 99,201 60
Where the children live
1.12 For 77,928 parents, information was available on
where the children lived. Of these, 46% had children living
with them, 54% had children living elsewhere, mostly
with other family members or friends. The proportion of
parents who did not live with their children increased from
51% in 1996 to 57% in 2000 (Table 1.4). Two-thirds of
mothers (64.4%), but only just over one third of fathers
(37.2%), lived with their children. Over the five years,
about 5% of parents had children living in care, rising from
3.8% to 5.6% between 1996 and 2000 (Table 1.4).
Risk profile
1.13 Following a review of the literature, a risk profile
was created using eight possible risk indicators recorded
in the database. Four drug-related risk factors were
chosen as indicators of severe and potentially chaotic
drug use and four social risk factors as indicators of
potential social insecurity.
Drug use risk factors:
a) daily heroin use
b) daily alcohol use with the use of illicit drugs
c) regular stimulant use
d) sharing of injecting equipment.
Social risk factors:
a) unstable accommodation
b) living alone or with strangers
c) living with another drug user
d) criminal justice involvement.
1.14 Stimulants included all forms of amphetamine,
cocaine hydrochloride and crack cocaine. ‘Regular use’ was
defined as using at least several days a week. ‘Daily use’
was defined as use on all or most days of the week.
‘Sharing’ was chosen instead of injecting as it indicates
that the user is taking clearly avoidable risks with his or her
health. ‘Unstable accommodation’ includes homelessness
and short-term stays in bed and breakfast accommodation
or hostels. ‘Living alone or with strangers’ means that the
user does not live with anyone they know (apart from their
children). As only a very small number of users live with
complete strangers, this item is hereafter referred to as
‘living alone’. ‘Living alone’ or ‘living with another drug
user’ are both used as an indicator that children grow up
without the presence of a non-using adult in the house.
As an indicator for ‘criminal activity’, we used referral into
treatment from a criminal justice agency.
1.15 Between 1996 and 2000 there were notable
increases in the proportion of users sharing, using heroin
on a daily basis, living alone or with other users, and a
Table 1.3: Client profile
% % Non-
Parents parents
Ethnicity White 96 97
Black 3 2
Asian 1 1
Employment Employed 30 29
Unemployed 70 71
Accommodation Owned 16 23
Rented 25 23
Council rented 45 33
Unstable 9 11
Other 5 10
Main drug Heroin 52 51
Methadone 11 9
Amphetamines 7 6
Cocaine/crack 6 5
Cannabis 7 11 
Other 17 18
Injecting Injecting 39 38
Non-injecting 61 62
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Table 1.4: Number of parents who have their children living with them or elsewhere
1996 1997 1998 1999 2000 All years
Parents live with children 3,612 5,747 7,967 8,884 9,671 35,881
Parents with children elsewhere 3,755 6,137 8,615 10,518 13,022 42,047
% living elsewhere 51 52 52 54 57 54
Parents with children in care 284 532 780 1,086 1,282 3,964
% with children in care 3.8 4.5 4.7 5.6 5.6 5.1
Total 7,367 11,884 16,582 19,402 22,693 77,928
decrease in the proportion of stimulant users (Table 1.5).
Non-parents and those with children at home showed a
similar risk profile, with a lower number of risk factors
than parents with children living elsewhere. Sixteen per
cent of users with children at home had no risk
factors at all, and only 10% had three or more risk
factors. In comparison, only 7% of users whose children
lived elsewhere had no risk factor, and 25% had three or
more risk factors (Figure 1.2). 
1.16 Figure 1.3 shows that the proportion of those living
with their children consistently reduces with increasing
risk scores. Of those with no risk factor present, 65%
live with their children, whereas only 28% of those with
three risk factors, and only 9% of those with six or
more risk factors have their children living with them.
An examination of individual risk factors also shows that
parents with children elsewhere consistently have the
highest prevalence of each risk factor independent of
gender (Figure 1.4). Users with children at home are the
least likely to share injecting equipment, use stimulants
regularly or have unstable accommodation. 
Figure 1.2: Total number of reported risk factors by
parenthood status (%)
Figure 1.3: Proportion of parents living with their
children according to number of risk factors present
Figure 1.4: Parenthood and individual risk factors
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Table 1.5: Trends in prevalence of risk factors 
1996 1997 1998 1999 2000
% sharing 5 5 6 7 8
% daily heroin users 53 50 50 52 58
% daily alcohol users 14 18 15 16 16
% stimulant users 33 31 31 31 28
% unstable accommodation 9 8 8 9 10
% living with other users 19 17 18 19 22
% living alone 23 26 27 27 29
% criminal justice referral 3 3 3 4 4
1.17 Users with children at home had a similar profile to
users without children, which would seem to contradict
the notion that children at home provide a protective
effect on their parents. Rather, it appears that users
whose children live elsewhere may be a higher risk
group. There was only a minimal difference between
men and women with regard to risk and thus differences
in risk scores according to where children live were
independent of gender. Whether the children of the
higher risk users were living elsewhere because of their
parents’ uncontrolled drug use or adverse living
conditions, or whether having children elsewhere has an
effect in encouraging riskier behaviour and worse living
conditions, are important questions that require further
detailed research. There was only a small difference in
the average risk score (2.1 vs 1.8) between parents
whose children had been taken into care and those with
children living elsewhere. 
1.18 With regard to individual risk factors, two factors
discriminated between parents with children in care and
those with children living elsewhere. Amongst those with
children in care, 32% lived with another user, but only
18% of those with children elsewhere did so. This may
indicate the protective effect of a non-using parent,
whereas if both parents are drug users and live together,
there is a greater risk of their child or children being taken
into care. The data also suggest that involvement with the
criminal justice system is also associated with a greater
risk that the child(ren) may be in care: 9% of those with
children in care but only 3% with children elsewhere were
referred to treatment by a criminal justice agency. 
Estimating the numbers of
children affected by parental
problem drug use1
England and Wales
1.19 We have estimated the total number of children
affected by parental problem drug use in England and
Wales in two ways. First, the number of problem drug
users presenting for treatment during the five years
1996–2000 has been combined with the proportion with
children and their average number of children and some
allowance made for ‘missing data’. Second, we have used
data from a Department of Health census of all problem
drug users in treatment facilities in England and Wales in
one year, combined with an estimate of the proportion of all
problem drug users who are not in treatment.
The five-year estimate
1.20 Over the five-year period, the treatment facilities
recorded information about 95,143 problem drug users
with dependent children. All data for the South West were
missing from the dataset. Adding 10.6% (the average
South West ‘contribution’ over the five-year period), gives
a total of 105,228 known drug-using parents (72,052
fathers and 33,176 mothers). We can therefore estimate
the numbers of children of both mothers and fathers who
have presented to drug services between 1996–2000.
On average there were 2.07 children per father and 2.05
per mother. We thus calculate there were 149,148
children with a drug-using father and 68,011 children with
a drug-using mother. As an unknown number of children
will have both mother and father in contact with services,
it is not possible to derive a single estimate of the number
of children. We thus estimate a minimum of 149,100 and
a maximum of 217,200 children of drug-using parents
from this five-year data set. The minimum figure would
apply if all the reported drug using mothers lived with all
the reported drug using fathers, and the maximum if none
of the users in this data set were ‘joint’ parents. Both
extremes are improbable and the true figure is likely to
be somewhere in between.
1.21 No data on parenthood were available for 29% of
clients. We have already stated (paragraph 1.9) that they
were similar to the others in terms of age and sex. It is
quite possible that the information was simply not
requested. However, it is also possible that many did not
have children and therefore perceived the question as
irrelevant or, conversely, that more had children but did
not answer the questions because of sensitivity regarding
their drug use. Unfortunately, we cannot determine which
of these explanations is correct. We have therefore
assumed the 29% of users for whom no parenting data
were recorded have dependent children in the same
proportion as the rest. We have also assumed that all
services provided at least some data on all clients in
treatment and that over the five years the number of
problem drug users not in treatment is balanced by those
who have ceased to be problem drug users. The
following estimates result: a minimum of 205,300 and
a maximum of 298,900 dependent children of drug
using parents. In the light of the assumptions we have
made, we believe these are very conservative estimates
and the true figure may well be higher.
The one-year census estimate
1.22 A census was carried out by the Department of
Health on all persons in drug misuse treatment services
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in the financial year 2000/01. There were 118,522 people
in treatment in England, and 9,770 in Wales, a total of
128,2923. Using these data, we can estimate the number
of children of parents in treatment during that year. Using
the gender ratios of the national treatment database,
there were 95,706 males and 32,586 females. As this
same data source shows that 53% of female drug users
and 40% of male drug users have dependent children,
we estimate there are 37,900 fathers and 17,200
mothers. Extrapolating from the mean number of children
(2.07 for fathers and 2.05 for mothers) gives a total of
78,500 children with drug-using fathers and 35,300
children with drug-using mothers. As above, because we
do not know how many children have both father and
mother in the data set, we estimate a minimum of
78,500 and a maximum of 113,700 children. 
1.23 The proportion of problem drug users in treatment
at any one time is unknown. However, recent research
suggested that about half of all problem drug users in
Greater Manchester were in treatment4. In some parts of
the country where services are less well developed, this
proportion will be lower. We have therefore assumed that
across England and Wales in the year of the census there
are three problem drug users not in treatment for every
two in treatment. Applying this ratio to the census
data suggests a minimum national prevalence
estimate of between 196,100 and 284,300 children
of problem drug-using parents during the one-year
period 2000/01. This is a very similar figure to that
derived from the five-year data set. 
1.24 We therefore estimate the number of children of
problem drug users in England and Wales is between
200,000 and 300,000. Based on population estimates
for 2000, this represents about 2–3% of the 10.6
million children aged under 16.
Scotland
1.25 To estimate the number of children of problem drug
users in Scotland, information was combined from two
studies and a large database on drug users seeking
treatment. These are: Estimating the National and Local
Prevalence of Problem Drug Misuse in Scotland5, the
Drug Outcome Research in Scotland (DORIS) and the
Scottish Drug Misuse Database (SDMD)6.
The prevalence study
1.26 The prevalence study applied capture-recapture
methods to provide prevalence estimates for problem
drug use in Scotland in 2000. Problem drug use was
defined as the use of opiates and benzodiazepines.
The study used data on problem drug users from the
following sources: SDMD (data on new attenders at drug
agencies and new treatment episodes with general
practitioners), the police (Misuse of Drugs Act) and Social
Enquiry Reports.
1.27 By analysing each of these databases it was
possible to identify a minimum total number of problem
drug users within Scotland. Analysis of the overlap
between the agencies enabled the research team to
model statistically the likely size of the hidden drug-using
population and thus estimate the overall prevalence of
problem drug use. On this basis, it was estimated that
the overall prevalence of problem drug use within
Scotland was likely to be in the region of 55,800 (95%
confidence interval 43,664–78,443) including 39,200
males and 16,600 females. This equates to about 2%
of the population aged 15–545. 
Drug Outcome Research in Scotland 
1.28 The DORIS study is designed to provide detailed
information on the effectiveness of different kinds of drug
treatment currently available to drug users in Scotland. In
total, 1,033 drug users beginning a new episode of drug
treatment were recruited to the study in 2001/02 from a
range of rural, urban and inner-city services. Initial
interviews covered basic biographical information;
treatment expectations; drug treatment history; contact
with other medical and community services; life situation;
current and previous drug and alcohol use; risk
behaviours; health; relationships; and legal status.
Subjects were also asked how many children they had
and with whom the children were living. Follow-up
interviews are being carried out over the next four years. 
Scottish Drug Misuse Database
1.29 The SDMD, which is broadly consistent with the
regional databases in England and Wales, obtains
anonymised demographic data on individuals in contact
with a range of drug services, including non-statutory
agencies and general practitioners. As the database
currently collates only information on new contacts at
agencies or new episodes of treatment by general
practitioners, it cannot on its own be used to provide
information on the total number of individuals attending
drug services in Scotland. 
Estimating the number of children with
problem drug-using parents in Scotland
1.30 Information on the number of problem drug users
in Scotland, the proportion who have children and their
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average number of children, can be combined to give
estimates of the number of children with drug-using
parents. From the prevalence study described above,
there are an estimated 56,000 problem drug users in
Scotland of whom about 30% are female. 
1.31 Information about the children of problem drug users
is collected by the SDMD and DORIS. Although the
SDMD only collects data about problem drug users in
contact with treatment services, it is by far the largest
and most important source of information on the nature
of problem drug use in Scotland. Among the 47,488
individuals recorded in the SDMD over the five-year
period 1996–2000, 20% reported living with one or more
dependent children7.
1.32 Although based on a much smaller number of drug
users than the SDMD, the DORIS study provides more
information relevant to parenting. In the SDMD, 32%
were female, the median age was 26 years, and 99.7%
were white. In the DORIS study, 31% were female, their
median age was 27 years, and 99.3% were white. Since
the SDMD and the DORIS study had a similar age,
gender and ethnicity profile and a similar gender profile to
the Scottish prevalence study, we were confident in the
validity of merging the data sets for combined analysis.
1.33 As indicated above, only the DORIS sample provides
information on the proportion of drug users that have
children and the number of children they have: 57% of
the males and 60% of females are parents. On average,
fathers had 1.83 children and mothers 1.77.
1.34 The total Scottish estimates of the number of
children with a problem drug-using parent can be based
on two simple calculations, one for males and one for
females. The estimated number of mothers or fathers is
multiplied by the average number of children they have.
Thus, the estimated number of problem drug-using
mothers is 10,100 (60% of the national prevalence
estimate of 16,800). Assuming each had an average of
1.77 children gives an estimate of 17,900 children with a
problem drug-using mother. The estimated number of
problem drug-using fathers is 22,300 (57% of the national
prevalence estimate of 39,200). Assuming each had an
average of 1.83 children gives an estimate of 40,800
children with a problem drug-using father. 
1.35 The available data do not permit the calculation of a
single estimate of the number of children of problem
drug users. This is because both parents of an unknown
number of children will be problem drug users. Simply
adding the two estimates in the above paragraph will
result in an unknown amount of double counting. We
therefore conclude that between 40,800 and 58,700
children in Scotland have a parent who is a problem
drug user. The minimum estimate would arise if all drug-
using mothers were joint parents with a drug-using
father, and the maximum if all drug-using mothers and all
drug-using fathers were joint parents with non-drug
users. Based on population estimates for 2000, this
represents about 4–6% of the 1 million children under
16 in Scotland.
1.36 Among problem drug users in the SDMD, 37% of
women and 13% of men were ‘living with dependent
children’. Among the DORIS participants, 42% of women
and 16% of men were ‘living with at least one dependent
child’. The slightly higher proportions in the DORIS
sample may be due to differences in the sampling
methods and/or the definitions employed by the two
sources. For example, all individuals living in either a
prison or residential treatment agency were excluded
from the DORIS calculation. The DORIS definition of
‘living with at least one of their own children’ may also
differ from the SDMD definition of living with a
dependent child (where the latter may or may not include
the dependent child of another, such as a new partner).
1.37 Combining data from the prevalence study and
DORIS allow the number of children living with a drug-
using mother and the number living with a drug-using
father to be estimated. Thus, there are an estimated
7,000 (42% of 16,800) female problem drug users who
live with one or more of their children. Similarly there are
an estimated 6,300 (16% of 39,200) male problem drug
users who live with their children. These figures can then
be multiplied by the average number of children living
with their mother (1.47) and father (1.46) in DORIS. This
indicates that there are 10,300 children living with their
mothers and 9,200 living with their fathers. Again, it is
not possible to provide a single estimate of the total
number of children resident with a problem drug user
because of the unknown amount of double counting due
to male and female problem drug users being parents of
the same children. We therefore estimate that between
10,300 and 19,500 children in Scotland are living with a
problem drug user. This represents about 1–2% of all
children under 16 in Scotland.
Discussion
1.38 Whilst these analyses have important limitations,
they are invaluable in providing an indication for the first
time of the number of children of problem drug users in
the UK. Our data sources mainly rely on self-reported
information. Given the sensitivity of the issues, it seems
more likely that drug users will under-report rather than
over-report the presence of children within their family.
In addition, because the available data for England and
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Wales are based entirely on people in treatment, and
make conservative assumptions about the proportions of
problem drug users not in treatment, the true figure could
well be higher. It is notable that our estimate for England
and Wales represents 2–3% of children under 16
compared with around 4–6% of children in Scotland.
This difference largely reflects the apparently higher
prevalence of problem drug use in Scotland. While a
somewhat higher proportion of the Scots had children,
on average they had fewer each.
1.39 Over half of these children are not living with at
least one of their natural parents, most usually living with
their mothers. Many are not living with either parent but
are with other relatives or in care. Very little is known
about the circumstances and needs of such children.
1.40 The analysis of the data from England and Wales
shows that the more serious and chaotic the parent’s
drug use risk profile, the greater is the likelihood that they
will not be living with their children. However, it was also
evident that many of the parents living with their children
had significant problems that could interfere with their
capacity as parents.
1.41 These analyses have only been possible because
information about their children has been sought from
large numbers of problem drug users and then recorded
on a national database. Since 2001, such information is
no longer collected in England and Wales. In order to
continue to monitor this important consequence of
problem drug use, we consider it essential to re-establish
a reliable method of recording if a problem drug user has
children and where they are living. 
References
1. Donmall, M C. The Drug Misuse Database: Local
monitoring of presenting problem drug use. London:
Department of Health, 1990. 
2. Donmall, M C. UK monitoring of problem drug users:
The Drug Misuse Database. A system based on
regional centres. European Addiction Research,
1999; 5: 185–90.
3. Department of Health. Statistics from the Regional
Drug Misuse Databases on drug misusers in
treatment in England, 2000/01. Bulletin 2001/33.
London: Department of Health, 2001. 
4. Millar, T, Gemmell, I, Hay, G and Donmall, M C.
Ongoing prevalence project. Personal 
communication, 2003.
5. Hay, G, McKeganey, N and Hutchinson, S.
Estimating the national and local prevalence of
problem drug misuse in Scotland. Glasgow:
University of Glasgow, 2001. 
6. Information and Statistics Division. Drug misuse
statistics Scotland 2001. Edinburgh: ISD
Publications, 2002. 
7. Meier, P S and Donmall, M C. A lifestyle comparison
of drug users with and without dependent children.
Manchester: Drug Misuse Research Unit, University
of Manchester, 2002.
28 Hidden Harm – Responding to the needs of children of problem drug users 
Recommendations 
1. All drug treatment agencies should record an agreed
minimum consistent set of data about the children of
clients presenting to them.
2. Whether a client or patient has dependent children and
where they are living should be included as standard
elements in the National Drug Misuse Treatment
System in England and Wales and in the Drug Misuse
Databases in Scotland and Northern Ireland and
should be recorded in the same way to allow
comparisons between regions.
Other recommendations about research follow Chapter 2. 
Chapter 2
The impact of parental problem drug use on children 
2.1 In the first chapter, we estimated there are between
250,000 and 350,000 children of problem drug users in
the UK. We also showed that the parents with the most
serious drug problems and the most chaotic lives are the
least likely to be living with their children. In this chapter,
we look at the impact on children of parental problem
drug use in more detail. This has been a particularly
neglected area for research, with most of the limited
number of studies being conducted in the US and only a
handful in the UK. Nevertheless, these and other work in
the fields of alcohol misuse and mental health enable
some important conclusions to be drawn.
2.2 In the Introduction, we defined problem drug use as
having serious negative consequences of a physical,
psychological, social and interpersonal, financial or legal
nature for users and those around them. Some of the
more common problems are listed in Table 2.1. Several
features of problem drug use in the UK are of particular
importance for their potential impact on children. First,
most problem drug users use several drugs (polydrug
use). Typical combinations are heroin and
benzodiazepines or heroin and cocaine but many others
may be used, depending on their availability. The vast
majority of problem drug users smoke tobacco and many
are heavy users of alcohol or cannabis. Taking drugs in
combination greatly increases the unpredictability of their
effects on the user. Second, many problem drug users
inject drugs, particularly heroin, for maximum effect and
value for money. This puts them at greater risk of
overdose, leading to unconsciousness and the risk of
death, and infection with blood-borne viruses such as
HIV and hepatitis B and C and other micro-organisms.
Third, many live in disadvantaged communities in
conditions of poverty and social exclusion. Many have
had difficult childhoods, fared badly at school or have
significant mental health problems. Their drug use may
thus be only one of several factors that may affect their
capacity as parents. 
2.3 Where drug use has become heavy and dependency
has developed, life for the user and those around them is
often chaotic and unpredictable. Crises can occur at any
time, for example due to overdose or injecting-related
infection, or due to arrest and imprisonment or eviction.
Of equal importance are the longer-term effects of drug
taking over months or years for physical health,
eg chronic illness due to HIV or hepatitis C infection,
and for employability, income and relationships. The
consequences of problem drug use for users themselves
are thus extremely wide-ranging and variable. What about
the impact on their children?
Growth and development
2.4 In order to understand the potential impact of parental
drug use on the child, the complexity of the process of
growth and development needs to be recognised1. This
depends on many interacting biological and social factors
which can be grouped under three headings:
• conception and pregnancy;
• parenting;
• the wider family and environment.
Table 2.1 Common features of problem drug use
Physical
Major injecting-related problems, eg abscesses,
blood-borne virus infections, overdose
Accidental and non-accidental injury
Psychological
Priorities dominated by drugs
Drug ingestion usually a daily event and an essential
requirement for everyday functioning
Unpredictable and irritable behaviour during withdrawals
Chronic anxiety, sleep disorders, depression, suicidal
behaviour
Post-traumatic stress disorder
Serious memory lapses 
Social and interpersonal
Family break-up
Loss of employment
Unreliability 
Chronic or intermittent poverty
Rejection by former friends and community
Victim or perpetrator of physical, psychological or sexual
abuse
Eviction and homelessness
Need to engage in property, crime, fraud, drug dealing
or prostitution to pay for drugs
Association with other persistent offenders
Financial 
Constant requirement to find large sums of money to
pay for drugs
Substantial debts
Inability to pay for basic necessities 
Legal
Arrest and imprisonment
Outstanding warrants and fines
Probationary orders 
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2.5 How a baby develops during pregnancy is affected by
a number of factors, of which the most important are:
• its genetic endowment;
• the mother’s general health and nutritional status;
• fetal nutrition during pregnancy;
• exposure to drugs and other toxins;
• exposure to infection;
• exposure to external trauma.
2.6 Parenting embraces a wide range of activities that
directly or indirectly affect the well-being of the child.
The most important of these are:
• basic care;
• ensuring safety;
• emotional warmth;
• stimulation;
• guidance and boundaries;
• stability.
2.7 There are also many aspects of the wider family and
environment which can influence children’s experiences
in one way or another. These include: 
• family history and functioning;
• the extended family;
• housing;
• employment;
• income;
• family’s social integration;
• community resources.
2.8 The way the child develops thus depends on a wide
range of influences. How these affect the child can be
considered under four headings or dimensions. These are: 
• physical health;
• education and cognitive ability; 
• identity and relationships; 
• emotional and behavioural development.
2.9 A child’s needs and capabilities change over time,
as do the potentially harmful experiences to which it is
exposed and the consequent harm. Factors that might
help to protect the child may also change over time.
We will briefly consider the effects on the child of
parental problem drug use during the following six
phases:
• conception to birth;
• 0–2 years;
• 3–4 years;
• 5–9 years;
• 10–14 years;
• 15 years and over.
Conception to birth
2.10 Drugs can damage the fetus at any time during
pregnancy, causing a wide range of abnormalities in
growth and development. These can range from the
immediate and catastrophic to much more subtle effects
that may not emerge until many years later. The British
National Formulary is the most authoritative source of
information on prescribing drugs in the UK. It lists over
800 prescribable drugs which ‘should be avoided or
used with caution’ in pregnancy. They include alcohol,
amphetamines, benzodiazepines, nicotine and opiates,
all of which are commonly used, and often in huge
quantities, by problem drug users. Trying to assess the
effects of drugs on the fetus is difficult, even when the
mother is taking a known dose of one prescribed drug
and is otherwise healthy and well nourished. It becomes
virtually impossible when the mother is using several
drugs in varying quantities and her general health and
diet are poor. If the child’s circumstances after birth are
unfavourable, it may also be hard to tell whether any
observed problems result from damage or disadvantage
before or after birth, or indeed may be a combination of
the two. For example, following prolonged exposure to
opiates or benzodiazepines during pregnancy, the baby is
likely to be very irritable and cry constantly (the neonatal
abstinence syndrome). If the mother is also oscillating
between drug-induced stupor and withdrawals, mother-
infant bonding is likely to be poor and she may neglect
the child. 
2.11 Longer-term effects of drug use during pregnancy
are even more difficult to detect. For example, the link
between smoking and lung cancer in smokers
themselves has been known for over 50 years but it is
only recently that serious long-term effects of maternal
smoking during pregnancy on children’s physical and
mental health have begun to emerge2, 3. Because data are
not routinely recorded on whether pregnant women in
the UK have been misusing drugs, no research has been
done to discover whether the children of problem drug
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users are any more likely than other children to have fetal
abnormalities.
Heroin and other opiates
2.12 Babies subject to prolonged opiate exposure during
pregnancy will almost invariably develop neonatal
abstinence syndrome (see section 2.31) which may be
prolonged and affect maternal attachment. However,
there is relatively little evidence from published studies
of significant long-term damage from fetal exposure to
heroin or other opiates. Opiate-exposed babies are more
likely to be smaller and premature, but it is unclear
whether this is due to the opiate itself or to other factors
such as maternal tobacco use or poor nutrition. There is
some evidence that opiate-exposed babies have delayed
early language development, but no statistically
significant differences have been found in other
measures of development4. There is no evidence that
maternal use of methadone, the mainstay of treatment
of opiate dependence, results in detectable fetal damage.
However, injecting heroin clearly carries greater risk to
the fetus through exposure to blood-borne viruses and
other infective agents from contaminated injecting
equipment or street drugs (see 2.17). 
Cocaine and amphetamines 
2.13 There is conflicting evidence about the impact on
the fetus of exposure to cocaine but sufficient reason for
serious concern. A recent review concluded there was
little evidence of damage up to the age of six years5.
However, a controlled study published in 2002 found that
cocaine-exposed children were twice as likely to show
delay in cognitive development by the age of two than a
control group6, and other studies have found more subtle
but consistent defects in the cognition and ability to
concentrate of exposed children at the age of six to
seven years7, 8. Furthermore, animal experiments have
shown that administration of low doses of cocaine during
a crucial stage of pregnancy can induce permanent
changes in brain chemistry and function9. There is little
evidence on exposure to amphetamines upon which to
base any firm conclusions at present.
Benzodiazepines
2.14 Most of the published research on drug-exposed
babies is from the United States where benzodiazepine
misuse is uncommon. There is thus little evidence to
indicate whether or not there are long-term
consequences from fetal exposure to high doses of
benzodiazepines. There is some evidence from animal
experiments that fetal exposure to benzodiazepines may
have a pronounced effect on subsequent adult responses
to stressful stimuli10. Neonatal abstinence syndrome is
considered in 2.31.
Tobacco and cannabis
2.15 The great majority of polydrug injectors are heavy
tobacco smokers. For example, a recent study of over 250
female problem drug users in Glasgow found that 98%
were cigarette smokers, with most smoking at least 20 per
day11. The impact of illegal drugs on the fetus will thus
often be in addition to that of tobacco. Tobacco has a wide
range of known effects on the fetus which can be apparent
before or shortly after birth12. These include higher
incidences of spontaneous abortion, still birth, low birth
weight, prematurity and sudden infant death. There is
growing evidence to link maternal smoking with
an increased risk of both physical and psychological or
behavioural problems in later life. A large, long-term
follow-up study has recently shown that maternal smoking
substantially increases the risk of the child developing
diabetes in later life2. A number of studies have shown that
the children of mothers who smoke cigarettes during
pregnancy have a substantially increased risk of behavioural
disorders3. The exact cause of these effects remains to be
established, but the most likely explanation is that they are
due to toxic effects of the constituents of tobacco smoke
on the developing fetus. Smoking cannabis during
pregnancy is associated with lower birth weight and with
subtle changes in the child’s neurological and psychological
performance that may persist into later life. It is unclear
whether this is due to the cannabis itself or the tobacco
with which it is often smoked. 
Alcohol 
2.16 Heavy drinking is not uncommon among problem
drug users. Fetal exposure to prolonged heavy maternal
alcohol use can lead to a range of serious developmental
problems including delayed neurological development,
growth impairment and a variety of physical
abnormalities. The baby is typically smaller and may be
difficult to care for13. Cognitive deficits together with
concentration, attention and behavioural problems may
handicap subsequent education and employment. There
is greater uncertainty about the impact of smaller or less
frequent exposure but the balance of evidence indicates
that it is not risk free. It is also unclear how a combination
of alcohol and illicit drugs such as opiates or cocaine
might affect the fetus.
32 Hidden Harm – Responding to the needs of children of problem drug users 
Blood-borne viruses
2.17 Infection with HIV, hepatitis C or hepatitis B virus
is a constant risk among drug injectors who share their
injecting equipment. Unlike in many parts of the world,
the prevalence of HIV infection among drug injectors is
currently low in most parts of the UK: about 3% among
female drug users in London and less than 1% elsewhere.
The prevalence of hepatitis C among drug injecting
populations in the UK is thought to average 30% in
England and Wales14 but exceeds 60% in parts of
Scotland15. Once infected with HIV or hepatitis C, most
individuals will become lifelong carriers with the potential
to transmit the infection to others. It has been estimated
that the annual incidence of hepatitis B infection among
drug injectors in the UK is around 1% per year16. However,
very few become chronic carriers and therefore the
number of female drug users who might infect their baby
with hepatitis B is much lower than for HIV or hepatitis C.
2.18 Transmission of these viruses from an infected
mother to her baby can occur during pregnancy or birth
or through breastfeeding. Antenatal transmission of HIV
infection occurs in up to 25% of cases where the woman
has not received anti-retroviral treatment, reducing to about
2% if treatment is given during pregnancy. Similar rates of
infection occur after birth if the baby is breastfed. Rates of
antenatal transmission of hepatitis B are even higher, but
infection can be prevented if the baby is immunised shortly
after birth. Prevention of HIV and hepatitis B infection thus
depends very much on antenatal diagnosis and treatment.
The transmission rate of hepatitis C from mother to baby
during pregnancy or birth has been found to be about 5%
in general population studies17 but was 12% among drug
injectors in an Italian study18. Elective Caesarean section
appears substantially to reduce the rate of transmission19.
Assuming a prevalence of hepatitis C among female drug
users of 30–60% and a mother-to-baby infection rate of
5–12%, between 15 and 70 babies per 1,000 pregnancies
among female drug injectors will be infected with hepatitis
C. To our knowledge, there have been no studies that
provide reliable information on the extent of mother to
baby transmission of hepatitis C in the UK. This is clearly
an issue that urgently requires more research. However,
the known facts indicate that it is essential that every
pregnant drug user who has injected drugs should be
offered testing for all three viruses and given appropriate
treatment and clinical management if found to be infected.
Maternal nutrition and general health
2.19 Poor maternal nutrition may have significant long-
term consequences for the health of the unborn child.
Over the past decade, evidence has mounted that a
mother’s general health and nutritional status during
pregnancy have a profound effect on the susceptibility
of the child to a wide range of diseases in later life, often
decades later20. Specifically, a maternal diet that is low in
green vegetables may result in folate deficiency,
increasing the risk of neural tube defects in the baby.
Problem drug use is often associated with poor diet,
typically high in sugar and low in high-quality protein,
fruit and vegetables21. Whilst there appear to have been
no published studies of the diet of pregnant problem
drug users, it is reasonable to assume that in many
cases their diet and nutritional status are sub-optimal.
Violence
2.20 There is the possibility of damage to the fetus due
to violence to the mother: women with serious drug
problems are at much higher risk of physical abuse by
male partners or if working as a prostitute22, 23. However,
there is no available evidence to indicate how often this
may result in fetal injury. The impact of actual or
threatened violence upon the physical and emotional
state of the mother is also difficult to ascertain but may
be considerable.
Antenatal care
2.21 A satisfactory outcome of pregnancy is much more
likely if the mother has received good antenatal care from
an early stage. Problem drug use may result in the mother
presenting to maternity services late in the pregnancy,
particularly if the woman is reluctant to attend due to
fear of being stigmatised. As a result, early problems
may not be picked up and addressed until it is too late.
The opportunity to stabilise drug use may be missed.
This aspect will be addressed in Chapters 4 and 7.
Conclusions
2.22 There is considerable evidence that at least some
drugs when used during pregnancy, notably tobacco,
alcohol and cocaine, have damaging effects on the fetus
that are likely to affect the child’s future health and well-
being. The true extent of fetal damage due to maternal
drug use remains unknown. Given the psycho-active
nature of the common drugs that are misused, often in
large quantities, their impact on the developing brain and
nervous system in particular must be a matter of
considerable concern. If the mother is a current or former
drug injector, there is a serious risk of transmission of
blood-borne viruses to the baby. The maternal use of
opiates, benzodiazepines and cocaine all cause neonatal
abstinence syndrome which can seriously compromise
bonding between mother and child (see 2.31). 
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From birth onwards
2.23 Table 2.2 summarises the main features of normal
growth and development from birth to adolescence across
four key dimensions. It emphasises the multi-faceted
nature of growing up and in particular the importance of
regularity and consistency. Table 2.3 highlights some of
the ways in which parental drug use can interfere with the
child’s development in these domains, either directly or
indirectly. It can be seen that its impact is potentially
global and can affect every aspect of the child’s
upbringing. How an individual child is affected will of
course vary enormously, depending on numerous factors.
The following sections summarise the research and
experiential evidence available to the Inquiry – both of the
damage that may be caused and of the factors that may
help to limit this. Chapter 3 will describe some aspects of
parental drug use from the perspective of the children
themselves. Chapters 4 and 5 will provide evidence of the
large number of children that social work services across
the UK are encountering, where parental drug use is a
major contributory factor to abuse or neglect.
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Table 2.2: Summary of main features of normal health and development and key protective factors in 
childhood and adolescence (adapted from Cleaver et al, 1999)
Age (y) Physical health Education and Relationships Emotional and
cognitive ability and identity behavioural
development
0–2
3–4
5–9 Regular medical and
dental checks
Balanced diet
Prompt treatment of
illnesses and injuries
Attending school
regularly
At least one friend
Increasing ability to
concentrate
By 9 able to read, write,
do sums
Notions of truth and
fairness increasingly
understood
Generally enjoys physical
closeness and confiding
relationship with main
care giver(s)
Sees self as
autonomous, generally
accepts own gender and
physical attributes
Peers increasingly
important and friends
valued
Will usually seek comfort
from adults when
distressed
Temper tantrums
diminishing with age
Family values absorbed
and child relies
increasingly on internal
controls
May help adults in home
but too young to take on
parental role
Ensuring normal growth
Balanced diet
Support for learning or
physical difficulties
Prompt treatment of
illnesses and injuries
Safe home environment
Regular attendance at
pre-school facility by 4
Most children can
concentrate well
Pretend play developing,
‘taking turns’ with others
Language skills fostered
by adult encouragement
and reading
Continued importance of
constant care giver(s)
Relationships with other
children, beginning of
sharing, helping and
comforting
Aware of own identity
and that of parents and
siblings
Learning about ‘good’
and ‘bad’
Gaining greater control
over behaviour
Normally control over
bladder and bowel
achieved
Usually friendly and
helpful
Often experiences
irrational fears, especially
of abandonment
Regular feeding, sleeping
and elimination
Regular attendance for
immunisation and
developmental reviews
Appropriate attention to
health problems
Early response to sounds
and voices, babbling by
1 year, speaking by 2
Beginning social play
by 6 months
Pretend play by
12 months
Attachment relationship
to at least one care giver 
Distinguishes important
figures in life by 6 months
Play mainly solitary
until 2
Relatively confident in
self by 2
Presence of person(s) to
whom child is attached
reduces anxiety, gives
child confidence to
explore world
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Table 2.2: Summary of main features of normal health and development and key protective factors in 
childhood and adolescence (adapted from Cleaver et al, 1999)
Age (y) Physical health Education and Relationships Emotional and
cognitive ability and identity behavioural
development
10–14
15+ Girls often unhappy with
their bodies
Regular drinking and
smoking and
experimentation with
drugs common
Sexual experimentation
Majority in full-time
education
Needs guidance to
ensure education is
properly planned
Exam stress common
Struggles to forge own
identity and understand
potential and limitations
Strong influence of both
parents and peers
Depressive feelings
common 
Any psychiatric disorder
in around 13%
Depressive disorders
twice as common in girls
Continued medical and
dental checks
Onset of puberty
Experimentation with
smoking and alcohol
becomes increasingly
common
Accidental injuries
common
Attending school
regularly
Parental support for
schoolwork important
Bullying common
Value of extracurricular
activities, eg sport and
music
Usually remains
integrated within family
Family values important
but may be opposed
Increasing time spent
with friends
Typical 10–11-year-olds
emotionally volatile but in
only about 7% of 10–14-
year-olds is behaviour
classified as disordered
Worries and fears usually
centre on school and
social issues
Table 2.3: Summary of main areas of potential impact on health and development of parental problem
drug use (adapted from Cleaver et al, 1999)
Age (y) Health Education and Relationships and Emotional and
cognitive ability identity behavioural 
development
0–2
3–4 Medical and dental
checks missed
Poor diet
Physical danger due to
inadequate supervision
Physical violence more
common
Lack of stimulation
Irregular or no
attendance at pre-school
Poor attachment to
parents
May be required to take
on excessive
responsibility for others
Hyperactivity, inattention,
impulsivity, aggression,
depression and anxiety
more common
Continued fear of
separation
Inappropriate learned
responses due to
witnessing, eg violence,
theft, adult sex
Withdrawal syndromes
Poor hygiene
Sub-optimal diet
Routine health checks
missed
Incomplete immunisation
Safety risk due to neglect
Lack of stimulation due
to parental preoccupation
with drugs and own
problems
Problematic attachments
to main care giver 
Separation from
biological parent(s)
Emotional insecurity due
to unstable parental
behaviour and absences
Hyperactivity, inattention,
impulsivity and
aggression more
common
Similarities to impact of mental health
and alcohol problems
2.24 Because problem drug use affects an individual’s
state of mind or behaviour, many of its effects on a
parent and her or his child-rearing capacity have
similarities to those resulting from parental mental health
problems and problem alcohol use1. Each may affect the
parent’s practical skills, perceptions, attention to basic
physical needs, control of emotion, judgement and
attachment to or separation from the child. Parenting
capacity can be further compromised if one or both
parents also have mental health or alcohol problems.
Separation and death
2.25 As shown in Chapter 1, many children of problem
drug users are not living with their biological parents.
The separation can take place at birth or at some time
thereafter and may be temporary or permanent. The
impact on the child of serious chronic parental illness
such as HIV or hepatitis B or C, or admission to hospital
for overdose or other drug use-related emergencies, may
also be considerable. Imprisonment or treatment at a
residential rehabilitation centre are other common causes
for enforced separation. A high proportion of chaotic
female drug users may quickly lose custody of their child.
For example, during the past decade around 30 female
problem drug users gave birth annually at the University
College Hospital in London. Many were heavy users of
opiates, cocaine and alcohol. On average, around seven
mothers did not go home with their child and a further
eight or nine no longer had their child by the end of their
first year24. A study of the lifetime experiences of 188
children raised by 70 methadone-maintained parents in
the US indicated high levels of lifetime separation. In all,
4% of the children were placed in adoptive care, 9%
had been in foster care and 1% had been placed in a
residential care unit at some point in their lives25. The
children spent significant periods of time being cared for
by people other than their mothers. Mostly they were
with relatives (43%) or their other parent (36%). However,
7% reported that their children were cared for by friends,
6% reported that they were left with no one and 4%
did not know who watched their children when they
were absent. Among 171 women attending services for
problem drug users in Glasgow, all of whom had had at
least one child, only 35% were still living with their child11.
The annual death rate among problem drug users is
around 1–2% – mainly due to overdose, accidental or
non-accidental injury, or, in some parts of the country,
HIV infection26. Losing a parent through separation or
death is therefore a much more common experience for
the children of problem drug users than for other children.
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Table 2.3: Summary of main areas of potential impact on health and development of parental problem
drug use (adapted from Cleaver et al, 1999)
Age (y) Health Education and Relationships and Emotional and
cognitive ability identity behavioural 
development
5–9
10–14
15+ Increased risk of problem
alcohol and drug use,
pregnancy or sexually
transmitted diseases
Lack of educational
attainment may affect
long-term life chances
Lack of suitable role
model
Greater risk of self-
blame, guilt, increased
suicide risk
Little parental support in
puberty
Early smoking, drinking
and drug use more likely
Continued poor academic
performance, eg if
looking after parents
or siblings
Higher risk of school
exclusion
Restricted friendships 
Poor self-image and low
self-esteem
Emotional disturbance,
conduct disorders,
eg bullying, sexual abuse
all more common
Higher risk of offending
and criminality
School medicals missed
Dental checks missed
Poorer school
attendance, preparation
and concentration due to
parental problems and
unstable home situation
Restricted friendships
May be required to take
on excessive
responsibility for
parent(s) or siblings
More antisocial acts by
boys, depression, anxiety
and withdrawal by girls
Teenage pregnancy
2.26 Many female problem drug users have at least their
first child in their teens. As shown in Chapter 1, among
over 7,600 teenage women attending drug services in
England and Wales in 1996–2000, around 20% had at
least one child. A recent study of 266 female problem
drug users in Glasgow found that two-thirds of those
who had given birth had had their first child before they
were 20. This compares with one-third of first childbirths
in the most deprived areas of the city and only 4% in the
most affluent27. Thus, in many cases, the problems of
drug use are compounded by parental immaturity and low
educational attainment. 
2.27 It is thus evident that the greater the degree of the
parent’s involvement in drugs, and the greater the range
of co-existing problems such as mental illness, low
educational attainment, troubled family background and
poverty, the less able she or he will be to fulfil the role
of parent and the greater will be the potential for harm to
the child. 
Resilience factors
2.28 Research on the effects of adversity on children
indicates that they are less likely to be seriously and
permanently affected if the adversity is mild, short-lived
and not associated with family break-up28. Children and
young people are more likely to overcome adversity if
they have:
• strong social support networks;
• the presence of at least one unconditionally
supportive parent or parent substitute;
• a committed mentor or other person from outside
the family;
• positive school experiences.
Research on families where there are parental mental
health or alcohol problems has identified other important
factors that can help reduce the harm to children and
which are likely to be equally relevant where there are
parental drug problems1:
• one or both parents receiving effective treatment;
• other responsible adults are helpfully involved in the
child’s care;
• the family’s routines and activities are maintained;
• there is a stable home with adequate financial
resources.
2.29 However, none of these factors is a guarantee
against harm, and, where adversities are continuous and
severe, their protective value will be diminished28. So
much depends on the complex interplay of circumstances
and personalities. One of the most predictable features of
the life of problem drug users is its inconstancy: apparent
stability can disintegrate with remarkable speed as drug
use escalates or illness, arrest or some other crisis
develops. Whilst the presence or absence of such
adverse or protective factors may have a bearing on the
vulnerability of children of any age, it is also important to
highlight how parental problems can vary in their effect
on children at different ages. This will be considered in
the following sections.
Birth to two years
2.30 The foundation of a child’s normal development is a
good relationship with a well parent or primary care giver,
usually the mother, who is consistently able to provide
nourishment, stimulation and protection from danger and
give the child a sense of well-being and security. Much of
the potential for parental drug use to damage the child in
these early months lies in the way it can obstruct or
corrupt this relationship. 
Neonatal abstinence syndrome 
2.31 Babies of women whose use of opiates, cocaine or
benzodiazepines during late pregnancy is heavy are likely
to experience withdrawal symptoms. These vary greatly
in severity and can last for days, weeks or even months
after birth. For example, among 35 babies born to female
problem drug users in Aberdeen in 2000, 20% had
continued or late withdrawal lasting many weeks29.
Typical symptoms include: irritating and high-pitched
crying, often for long periods; rapid breathing and heart
rate; disturbed sleep patterns; sweating and fever;
vomiting and diarrhoea; and feeding difficulties. More
prolonged withdrawals have been noted in babies of
mothers using benzodiazepines as well as opiates30, 31.
Babies in withdrawal will generally require extended
hospitalisation, with consequent implications for
resources. The more severe withdrawals are and the
longer they last, the greater their impact is likely to be on
bonding between mother and child. If prolonged
withdrawals are not recognised, the baby may be allowed
home too early, worsening an already fraught situation,
particularly if home support is inadequate. The
combination of an irritable baby that is constantly crying
and a stressed and depressed or anxious mother, do not
favour healthy bonding. Moreover, there is evidence that
babies with the neonatal abstinence syndrome may have
reduced visual responsiveness, that is, they do not look
at other people or respond on visual contact29.
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Attachment may be further harmed if the mother’s
concentration is impaired by either intoxication or her
own withdrawals. Mothers with drug problems have
been shown to respond less frequently to their baby’s
cues and, when they do, are more likely to do so in a
controlling manner32. The quality of the bonds established
in infancy influences their subsequent relationships and
interactions with others33. Follow-up studies have found
that children rated as securely attached by age two were
at a later age (up to 11) more confident, had more
friends, higher self-esteem and social leadership than
insecure children34, 35.
Other physical health problems 
2.32 If not recognised and addressed before birth, HIV
can be transmitted during pregnancy, birth or breast-
feeding, leading to serious illness and death during early
childhood. If the mother is a carrier of hepatitis B, the
baby can also become a carrier, with lifelong
consequences, unless it is immunised at or shortly after
birth. Although intrauterine transmission of hepatitis C
appears rare, the extent to which it can be transmitted
through close household contact remains to be
established. Breastfeeding rates among female problem
drug users are generally extremely low, thereby depriving
their children of the proven health benefits of breast
milk36. Most problem drug users are heavy tobacco
smokers: environmental tobacco smoke results in higher
rates of sudden infant death, respiratory and ear
infections. Access to basic health care may also be
compromised. The Inquiry received evidence from a
recent study in London which found that the children of
problem drug users were less likely than comparable
children to be registered with a general practitioner, to be
fully immunised or to receive routine developmental
checks37. Children whose parents are not registered with
a general practitioner or are homeless may be especially
likely to be denied adequate primary care. 
Neglect and abuse
2.33 Problem drug use can contribute to neglect and/or
physical, psychological or sexual abuse of children from
the earliest age38, 39. Drug dependency is a chronic
relapsing condition, typically marked by dramatic swings
between relative stability and chaos. During times of
chaos, children become especially vulnerable, as meeting
their physical, social and emotional needs conflicts with
the parent’s need to meet the demands of their drug
habit40. Specific examples of how the child may be
affected are many: when intoxicated, parents may fail to
hear their child’s cries or notice it is unwell; they may
accidentally smother it when unconscious due to drugs;
they may leave the child unattended when seeking
money or drugs; they may provide it with inadequate
food, warmth or clothing due to insufficient resources
or inclination. As the infant becomes more mobile and
inquisitive, so the risk of accidents increases (see Box
2.1). Chapter 5 includes data from recent case reviews in
London and Scotland showing that parental problem drug
use is one of the most frequent causes of child abuse
and neglect.
Developmental problems 
2.34 There is inconclusive research evidence regarding
the impact of parental drug use on early behavioural and
cognitive development. Comparing infants of problem
drug users with those of comparable non-users4 found no
significant differences in motor, cognitive or behavioural
development at 6–18 months, although early language
development was impaired in the drug-exposed group at
24–30 months. However, it is unclear whether the
mothers in these studies are representative of problem
drug-using mothers as a whole: for example, they are
generally recruited from treatment services and therefore
may be less chaotic than women not in treatment. There
is also no published information about the many children
who are separated from both parents and are living with
relatives, foster parents or in residential care. Based on
studies of infants whose parents have mental health or
alcohol problems, the more preoccupied the parent is
with her or his drug use, the greater their inconsistency
and unpredictability and the smaller the amount of
stimulation and emotional warmth given to the child.
As a result, the likelihood of slow development and
behavioural problems such as hyperactivity, impulsivity
and aggression will be greater1.
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Box 2.1: Fatal consequences of
neglect
A crown court accepted a 23-year-old woman’s plea
of guilty of the manslaughter of her two-year-old son
who had died from drinking her methadone. She was
smoking heroin in another room when the child found
the bottle and drank the methadone. He had quickly
become ill but his mother ignored the symptoms and
took him shopping by bus. On returning home she
put him to bed on a sofa and spent the evening
smoking more heroin. She went shopping again the
next day, before his death, leaving the boy with a
16-year-old babysitter who was also a heroin addict.
(The Guardian, 8 October 2002) 
Parenting skills and styles 
2.35 The nature and quality of parenting can have a
major bearing upon the causation or resolution of
problems in a child’s development41. Parents develop a
range of parenting skills based on their own experience
of being parented, advice from family and community
networks, and social and cultural norms. A number of
studies have considered the parenting effectiveness of
drug-using parents. Most have focused on women
attending treatment services. Some compared drug-using
parents with those who do not use drugs42, 43, 44. Others
examined the relationship with the extent of drug use
and associated problems45. Despite their methodological
limitations, they consistently found that problem drug
users were more likely to use authoritarian or neglecting
styles of parenting. The heavier the drug use, the poorer
the parenting skills and attitudes were likely to be.
However, increasing drug use is also associated with
poverty, lack of social support, troubled family histories,
having a first child at an earlier age, and fewer years of
education. Thus, drug use may both reflect and
exacerbate a range of other difficulties, all of which
undermine parenting capacity.
Resilience factors
2.36 Factors which may reduce the risk of harm to the
child at this age include: the presence of another caring
adult who can respond to the baby’s needs; sufficient
financial resources and good physical standards in the
home; regular supportive help from a primary health care
team and social services; and an alternative safe and
supportive residence for mothers subject to violence or
the threat of violence1.
3–4 years
2.37 At this age, parental problem drug use can continue
to jeopardise the child’s development in many ways. The
child may be left unsupervised or be neglected when the
parents are under the influence of drugs or absent from
the house obtaining drugs or the money to buy them.
Hygiene and diet may suffer. They may be exposed to
direct physical violence or emotional abuse if the parent
loses his or her temper, for example when suffering from
drug withdrawals. If the parents are preoccupied with
finding drugs or the money to buy them, they will have
less time to stimulate the child through play or reading.
For a variety of reasons including disorganisation and lack
of self-esteem, they may fail to enable the child to attend
pre-school facilities.
2.38 Two studies compared drug-using and non-drug-
using women who had pre-school children. They found
that the methadone-maintained mothers were more likely
to parent their children through negative command43, 44.
In another controlled study, children of pre-school age
born to heroin dependent mothers or fathers were
compared with ‘environmentally deprived’ children and
those in families of moderate to high social class46. They
found that over half the children born to heroin-dependent
parents were assessed as having problems with
hyperactivity, inattention, impulsivity and aggression.
However, the children from ‘deprived’ backgrounds
functioned on average even less well than the drug-
exposed children. This suggests that the quality of the
physical and psychological home environment plays a
crucial role and that parental drug use is only one way in
which it can be jeopardised. Other studies have come to
similar conclusions45, 47, 48. In addition to those listed in
2.36, protective factors at this age include regular
attendance at pre-school facilities. 
5–9 years
2.39 It is notable that much less research has been done
on children of problem drug users who have reached
school age. There is no reason to believe, however, that
the potential of parental problem drug use to harm the
child has gone. By this stage, children should be
attending school regularly with parental support and
making good progress in learning to read and write. They
should have at least one good friend, and the emotional
outbursts that are common among toddlers should be
much diminished. However, a study of 50 primary school
age children of problem drug users in Dublin found that
their school attendance, their homework and their
concentration in class were all on average poorer than
those of 50 other children from the same area and socio-
economic background49. Fifty-eight per cent of children of
drug users had attendance problems compared with only
10% of the control group. A similar proportion of the
drug-using parents were seen as having low levels of
involvement with their children’s school and schoolwork.
The drug-using parents found it difficult to set and sustain
family routine because they were often tired or in
withdrawal. In particular, active use of heroin was
associated with disruption of physical care for their
children and financial instability. The parents were often
either physically or emotionally unavailable to their
children, with prolonged absences being common due
to imprisonment, hospitalisation or residential drug
treatment. The children of drug users were also more
likely to be seen by their teachers as having behaviour
problems – either being abnormally withdrawn and
anxious or having difficulties with self-control. However,
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some of the children of drug users did appear to be
developing well with few social problems. 
2.40 In a study of 222 parents with children aged six or
over, greater drug use in the past year was associated
with less supervision of the child, more punitive forms of
discipline, less discussion and positive involvement with
the child, and more disagreement between partners in
relation to disciplining the child45.
2.41 At this age, the children of drug users are very likely
to have seen their parents using drugs in the home and to
have seen other relatives, friends or strangers coming into
their house to use and/or deal in drugs. Exposure to crime
or its consequences is also common. In Hogan’s study,
drug-using parents were far more likely to say that their
child had been with them when they committed a crime
(24% vs 2%), had seen parents being searched by the
police or had visited someone in prison (34% vs 4%)49.
Drug users were typically reluctant to tell their children
they had been imprisoned. Parental example involving
drug taking, dishonesty, deceit and criminal behaviour is
likely to legitimise and normalise such behaviour in the
eyes of the child. During this period, the children of
problem drug users remain at greater risk of physical
injury or sexual abuse or of witnessing physical or
psychological violence to others. This may contribute to
anxiety or guilt. On the other hand, they may be more
likely to have to assume greater than normal responsibility
in the home due to parental incapacity or absences.
2.42 In addition to the resilience factors listed in 2.36,
regular attendance at school and having at least one
good friend are seen as important protective factors.
10–14 years
2.43 Interviews with the children of drug users indicate
that children’s understanding of their parents’ drug
problems typically falls into place around the age of
10–12 (see Chapter 3). Children at this age may be
cautious about exposing family life to outside scrutiny
and therefore friendships may be restricted and social
isolation severe. Those children who have taken a role as
a carer may feel stigmatised and undervalued. If parental
drug use diverts money away from household items such
as clothes, adolescents may find it difficult to keep up
appearances and friendships may be further jeopardised.
Due to parental emotional unavailability, the children of
problem drug users are more likely to be left to cope
alone with the physical changes of puberty. The
persistent impact of parental problems leads to a higher
likelihood of emotional disturbance and behavioural
disorders including bullying and offending25. Due to poor
parental supervision and role modelling and low self-
esteem, there is a high risk of experimentation with
smoking, drinking and drugs. Substance misuse at an
early age is strongly associated with both parental drug
use and associating with a delinquent or drug-using
subculture50. Taking the same road to problem drug use
as their parents is thus a real possibility, completing a
tragic inheritance of wasted potential. 
2.44 Educational under-performance remains likely,
due to poor school attendance, home preparation and
concentration at school. Kolar and colleagues25 found
41% of problem drug-using parents had a child who
had repeated a year at school, 19% who had truanted
and 30% who had been suspended from school at an
average age of 12 years. Sowder and Burt51 reported
similar problems as well as lower IQ scores and
perceptual motor performance than control children
from the same neighbourhood. 
2.45 Resilience factors at this stage include: sympathetic,
empathetic and vigilant teachers; belonging to organised
out-of-school activities; having a mentor or trusted adult
with whom the child is able to discuss sensitive issues;
a mutual friend; unstigmatised support from relevant
professionals; and information about who to contact in
a crisis.
15 and over
2.46 Substance misuse by teenagers whose parents have
serious drug problems becomes ever more likely as they
get older50. Feelings of isolation and low self-esteem may
generate a wish to escape either physically or through drink
or drugs, thus potentially placing the young person in a very
vulnerable position. Teenage offending is also strongly
associated with early substance misuse. Early sexual
activity is much more likely among those who misuse
substances at an early stage, with the consequent risk of
pregnancy or sexually transmitted diseases. Young female
problem drug users in particular may resort to prostitution
or sexual favours to pay for drugs or unpaid debts as drug
use escalates. A disadvantaged childhood is likely to
culminate in the young person’s failure to achieve his or her
full potential at school, thereby seriously affecting future
opportunities for work and personal advancement.
2.47 Resilience factors which may help to diminish the
impact of parental drug use include regular attendance at
school or further education, a job and a relationship with a
trusted adult in whom the young person can confide.
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Children who no longer live with their
parents
2.48 Little is known about the circumstances of the many
children who have been separated from their parents and
live with other relatives or friends, or have been fostered,
adopted or accommodated in residential care. There has
been no published research regarding the quality and
stability of their relationships with care givers, their
physical environment or their outcome. Inevitably, there
will be a wide range of arrangements, ranging from stable
and supportive to inconsistent and potentially harmful.
This is an area where more research is needed. It is
already known that children who are taken into residential
care tend to do badly at school with a high proportion of
exclusions, and subsequently with high rates of
homelessness and drug dependency52, 53. From the limited
information available it would appear that children who are
adopted are most likely to have a satisfactory outcome46. 
2.49 The picture that emerges from this review is
depressing but not unexpected. Parental drug use has the
potential to interfere with virtually all aspects of a child’s
health and development. The more severe the drug
problems and the longer the child is exposed to them,
the more serious the consequences are likely to be. Fetal
exposure to drugs may already cause significant physical
and mental deficits. Parental drug use itself will typically
be combined with other disadvantageous factors
including poverty, parental mental health problems and
low educational attainment to create a parenting
environment that falls dangerously short of the ideal.
The outcomes are likely to be less satisfactory than if the
parents had not used drugs, leaving the young person at
best less well equipped to fit happily and productively
into his or her community, and at worst seriously
disadvantaged physically, psychologically or socially. 
2.50 The picture is not entirely bleak however. Many
children appear to be remarkably resilient. Various factors,
of which the most important may be the presence of a
consistent caring adult and freedom from poverty, can help
to diminish the impact of parental drug use on the child. 
Weighing the research evidence
2.51 To anyone familiar with the hundreds of studies of
problem drug users that have been conducted in the UK,
it comes as a shock to discover that virtually none has
focused on their children. We believe this is both due to a
lack of awareness of the problem by researchers and
policy makers and because carrying out research on the
children of problem drug users is extremely difficult. The
few published studies that exist are mainly from the
United States, where patterns of drug use and the social
context may be very different from the UK. For example,
the prevalence of cocaine use may be higher and the
ethnic mix different. Not all the findings may therefore be
relevant to the UK. They also only give a very partial view
of reality. Most feature parents (usually mothers) in a
treatment programme who have agreed to be
interviewed. Consequently, they are unlikely to involve
the most chaotic and non-compliant parents whose
children may be more at risk. In addition, the capacity of
the studies to reveal exactly what is happening to the
child is very limited. Most are largely dependent upon the
parents’ versions of events, backed up by assessment
and examination of the children, usually at one point in
time or over a short period. The opportunity to observe
what goes on at home day after day and week after
week is not available. Because a child’s development
depends so much on what occurs over months and years
in the home situation, these are serious shortcomings.
Furthermore, the majority of the studies focus on
pregnancy and the early stages of childhood and on those
children who continue to stay with at least one parent.
There is precious little about older children or those who
no longer live with one or both biological parents.
Attention has also tended to focus on mothers who
misuse drugs and there has been virtually no research on
the role of fathers who misuse drugs54.
2.52 Despite the shortage of formal studies, it would be
wrong to assume there is insufficient information upon
which to act. When the evidence from published work is
set alongside the analyses in Chapter 1, the harrowing
testimony in Chapter 3 and the reports to the Working
Group from London, Manchester, Liverpool, Sheffield,
Dublin, Glasgow, Aberdeen and elsewhere, a compelling
picture emerges of disadvantage and distress
experienced by a huge number of children in this country.
Nevertheless, it is clear to the Inquiry that much remains
unclear or unknown. While we realise that gaining access
to the children of problem drug users and their families is
fraught with difficulty for a host of reasons, we believe it
is essential to conduct a programme of well designed and
adequately resourced studies. 
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Chapter 3
The voices of children and their parents
Introduction
3.1 Most of what we know of the children of problem
drug users is contained within statistics that tell of
numbers, risk and poor outcomes. We know little of the
experience of growing up in drug dependent families
from the point of view of the parent, and still less from
the child’s perspective. Through highlighting parents’ and
children’s descriptions of living with problem drug use,
the purpose of this chapter is to breathe life into those
statistics and provide a greater sense of the impact of
drugs on family life and on children in particular. 
3.2 Only a small proportion of children of problem drug
users come to the attention of social services. For some
children, their parents’ drug problem will not be harmful.
Others may be at risk but they have not been recognised.
For many others, their parents’ drug problem may not
expose them to such risk that warrants social services’
intervention yet amounts to a pernicious lack of attention,
care and interest that undermines these children’s well-
being and development. The needs of these children may
be less acute than those of the children at risk but may
just as easily translate into damaged childhoods and poor
adult outcomes. Drawing on the small number of existing
qualitative studies in this area, this chapter focuses on
this more chronic but perhaps less visible experience of
need. Particular use is made of data from a Glasgow
study in which problem drug-using parents and their
children were interviewed. The insights provided by the
children and young people have particular relevance here.
Disrupted households
3.3 There were parents in all of these studies whose drug
problem was sufficiently under control for it not to
impinge upon the care of their children. However, for
most parents the chronic relapsing character of drug
dependency adds a large element of volatility into the
picture as they oscillate, often quite dramatically, between
periods of controlled drug intake and relative stability and
periods of escalating drug use and instability. Something
of the speed with which things can change can be heard
in the following interview extract taken from a Glasgow
study of problem drug-using parents and their children1:
“There would be times where if I had plenty
of drugs or I was like on a period where I
was controlling drugs that I would be
acting normal, but they widnae last very
long, maybe a couple of weeks.”
3.4 During periods of escalating drug use children may be
swept along in the wake of their parents’ preoccupations
with getting and using drugs, and their needs can take
second place to those imposed by the drug habit. This
was described by one of the parents who took part in a
consultation for Liverpool Drug and Alcohol Action Team2
when she said:
“The way the family would be would
depend on what drugs they had the night
before. There might not be a typical
morning – every one would be a bit
different. It’s always up and down,
you’re not guaranteed you’ll get money,
sometimes you might get money,
sometimes you might get arrested.
Anything can happen.”
3.5 This now recovering parent powerfully conveyed the
predominance of drugs in her and her son’s life at that
time3. 
“I was running about with folk that were
injecting and I was injecting myself. I was
taking temazepam, Valium, acid, really just
anything at all. Not eating or sleeping, my
house was a mess, folk coming into my
house at all hours, folk having parties at
my house. It was disgusting the lifestyle I
was leading and it was scary as well ‘cause
I had my wee boy with me and he was
seeing everything that was going on
around him.”
3.6 This mother in a study of drug-using parents in
Dublin4 noted the financial drain that drugs were prior
to her stabilising on methadone:
“I got paid on a Thursday. I’d wake up on a
Friday and wouldn’t have a penny and I’d
be hiding from people I owed money. Now
that I’m on methadone I have it. There’s a
big difference now.”
3.7 During those times when drugs are in the
ascendancy, children can be chronically vulnerable to not
having their social, emotional and physical needs met,
particularly if there is no other social support available to
ameliorate the impact of drugs on family life. Mundane
routines like meal and bed times might become wholly
uncertain with parents rushing between places to find
money and secure drugs. One gets a sense of this in the
following accounts from the Glasgow study, the first from
a methadone-maintained parent of a then five-year-old boy.
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“...Now some nights I wisnae getting back
till six o’clock so that the wean [child] was
coming home from school, nobody in, so
he was putting his wee school bag and
things underneath the hedge and going
away and playing about the streets until
I came home. And it was a case of I’d be
away looking for ma fix and couldnae go
home until I got that, knowing fine well
that the wean was up the road playing
about, waiting on me coming back.”
In the second account, this young woman (both of whose
parents had a drug problem) recalled a childhood
dominated by drugs:
“...We didn’t have any routines really,
everything revolved around the drugs
always.” I asked about food being available.
“No there wasn’t much food about...maybe
the day they got paid [benefit] there would
be a dinner and maybe the day after but then
there would be nothing again...It wasn’t like
there was nothing at all, there would be
bread and that but not much else.”
3.8 There is a fine line between being a child in need and
a child at risk of significant harm. The situation of the first
child certainly indicates a risk of harm through inadequate
supervision. At that time the parent’s preoccupations with
drugs meant that his needs came second, drugs
punctuating the child’s access to shelter, food and
clothing. 
Exposure to parental drug use
3.9 Many parents spoke of their efforts to conceal their
drug problem from their children. They would hide drugs
and injecting equipment and try to use drugs when
children were out or asleep. However, parents in the
Dublin and Glasgow studies spoke of their difficulties in
maintaining this front and the times it had ruptured, as in
the following two extracts, first from the Dublin and then
the Glasgow study:
“I did use in front of her when she was
younger, thinking she didn’t cop but she
did, I’m not going to lie. When she was
about three or four, she put a piece of
string around her arm and started tapping
her arm, mimicking me.”
“I walked in on them once when I was a
wee boy and I saw them [mum and uncle]
taking stuff...and other people that were in
the house taking it....That’s the first time I
caught them and they just...they started
doing it in front of me, didnae hide it then.”
3.10 The children and young people interviewed in the
Glasgow study indicated that they had known about their
parents drug problem long before their parents thought
they did1. 
“I was seven, but she didnae know until I
was about 10...My Ma’s boyfriend brought
all these people up to the house and that.
But my Ma didnae want them in but he
brought them in anyway. And they were
taking stuff in the living room and all
that...and I was going to the kitchen to get
a drink and I seen my Ma taking something
and then she didnae know that. And then
sometimes, I knew where she hid all her
stuff when she was taking it and I’d go and
I’d find them and all that but she didnae
know. And then her meth, she said it was
just medicine for her back and all that
because she’s got like loads of back
troubles. But we knew that wisnae true
either, we knew what it was for and all
that and she only found out a wee while
ago that we knew all that.”
Exposure to criminality
3.11 The illegalities and high costs of sustaining a drug
habit mean that most problem drug users have contact
with the criminal justice system in some form and often
use criminal means to finance their drug habits. Parents
in the Dublin study reported trying to shield their children
from knowledge of the drug-related nature of their
crimes, as this father described:
“He knows why I’m here. He knows it’s
from crime but not drugs. I’m a criminal,
he’s seen me and [his mother] committing
crimes...times where she wouldn’t pay for
anything same as meself. He knows the
police has us here.”
3.12 As with the father above, many parents reported
that their children were aware of and sometimes involved
in crime-related activities. Most commonly, this took the
form of shoplifting, as is reported by this recovering
parent3:
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“My oldest boy was treble streetwise cos
he was brought up that way. He’d been in
the jail and things like that with us [visiting
relatives] and I’d take him out [stealing]
with me, get the jail and my mum would
need to come down to the police station
and get him and things like that.”
3.13 However, it was also the case that children were
exposed to drug dealing, which might take place in their
homes for periods at a time. The mother of this young
boy in the Glasgow study described how her young son
was subjected to a terrifying ordeal when men broke into
her high-rise flat to steal the heroin that was being dealt
from there:
“I wasn’t there...I came in and the fellas
that were robbing us, we knew them...
When I got in the house I realised, ye know,
that we were getting robbed at knifepoint.
This was 14 up this happened, where we
stayed, and they knew that there was
heroin 18 up as well and then asked me to
go up and chap the door so the girl would
open the door and I said no so they
grabbed ma son Eamon with the knife and
they got him to run up and chap the door
but I ran with Eamon and I was saying ye
know ‘get your hands off ma baby’ and all
that and there was screaming going on and
everything was going on and wee Eamon
was screaming and I’m pulling Eamon and
they were pulling Eamon and I’m saying
‘get yer hands off ma son’ and the wean
chapped the door and I’ve grabbed him
and ran right down the stairs with him.
Em, that was it, I knew enough was
enough, ye know, I couldnae cope anymore,
it was a shame for them, they were just
roaming the streets, I was letting them do
what they wanted.”
Education
3.14 For some parents school was a haven within which
they knew children would be fed and protected from
exposure to drugs, and this was an important factor
motivating their attendance. This teacher in the Dublin
study commented with regard to one of the parents,
“I think that mother is quite concerned for his education
and does her best. She is committed to ensuring [he]
attends school daily because even if they sleep in she
brings him to school later.” However, the Dublin study
also noted high rates of absences, late attendance and
academic difficulties among the children of problem
drug-using parents. As this teacher commented on a
four-year-old girl in her class:
“Some days she is obviously upset coming
to school and does little work those days.
She is an able, bright child who is not
realising her full potential. She is bringing
a lot of baggage to school with her, which
is causing concentration problems.”
3.15 This 14-year-old girl described her ambivalence about
attending school when her parents were problem drug
users:
“...When I went to school I thought right I’ll
not get shouted at, I’ll no’ get hit and I’ll
no’ get the rest of it and I’ll no’ see them
taking drugs and I thought at school, at the
same time, kinda thing, what’s gonnae
happen the day when I’m not in the house?
What’s gonnae happen, what’s ma Mum and
Dad gonnae do the day kinda thing?”
Some children interviewed in the Glasgow study reported
that they stayed off school out of anxiety over what
might happen to their parents whilst they were away. 
“And just I used to stay off tae make sure
my Ma didnae get drugs and all
that...‘Cause I hate it...I’d follow her and
not let her do it...like I would make sure
she stayed in the house with me.”
3.16 Many of the children in the Glasgow study reported
frequent moves of address with the result that they were
enrolled in numerous schools and in some cases did not
go to school at all. One boy who had only ever attended
school infrequently could not recall how many schools he
had been to. For part of this time his non-attendance was
related to his efforts to avoid his parents drug use and drug
dealing by deliberately choosing to sleep during the day:
“I preferred that cos that way I never saw
much. I just stayed up all night watching
telly...”
His efforts to block out what was happening meant that
he did not go to school or make friends, which inevitably
further compounded his isolation from his peers.
3.17 Some children either were encouraged to stay at
home in order to take on caring responsibilities for
younger siblings or decided for themselves that they
were needed at home rather than at school. In the
Liverpool consultation, the children in constructing
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scenarios assumed that the eldest sibling would take on
responsibilities that precluded attendance at school:
“Rebecca doesn’t go to school. She stays
at home to look after Julie and Christopher
[the younger children]. She cleans up in the
house. She has to mind them.”
Young carers 
3.18 These were lives often burdened by responsibilities
to look after parents, siblings and the house. Parents
described how even from an early age the eldest children
had to become responsible for themselves and take on
the care of others:
“He [her four-year-old son] was doing
everything for himself...so grown up it
made me feel, ‘Oh OK he doesn’t need
me’...It got to the stage where he was
having to look after his wee brother. He
was sort of having to play mummy and
daddy, y’know. He’d get up in the morning
and make his bottle because mummy and
daddy are lying in the bed sparked out
from the night before.”
3.19 One 13-year-old girl described how up until very
recently she had assumed guardianship of her baby brother
out of an understanding that her mother was too immersed
in her drug problem to care safely for him. 
“I’d be left with Ian and all that and I had
to like take care of him and all that but she
[her mother] didnae really know. She’d
come round for a wee while and wake up
and all that but then she’d go and take
more stuff and she’d be sort of out of it and
she couldnae even bloomin’ boil a kettle or
something to make his milk or something.”
However, whilst she loved her brother, she resented the
fact that she was placed in this position as it meant she
could not go out to play with her friends and often
missed school. Furthermore, she was often overwhelmed
by anxiety as to his welfare when she was not in close
proximity to him.
Being there
3.20 Parental drug use was not a neutral experience for
these children and young people. It had deep-reaching
ramifications for them, which tended to be played out in
their subsequent behaviours. It is notable that the children
and young people interviewed in the Glasgow study
seldom referred to situations where they had been at risk
of harm. Their focus was not risk, nor particularly their
experiences of material deprivation, rather it tended to be
the social and emotional effects of living with parents who
too often put their drug-related needs first. Primarily these
children and young people described feelings of hurt,
rejection, shame, sadness and anger over their parents’
drug problems, and it was with difficulty that they lived
with these feelings. They often expressed a deeply
emotional sense of absence and isolation which was
conveyed in the often-used phrase that their parents were
not ‘there for them’. As for example this young woman
who struggled to come to terms with her mother’s drug
use: “She was never there for me, it must’ve been a bad
thing cos she was never there”. Another 14-year-old girl
said that her parents’ drug use made her feel:
“different, like they didnae care for me,
other folk were like, ‘I’m doing this with
my mum and dad the night’...and I’d be
saying ‘oh aye so am I’...but they’d be away
using or something...”
3.21 A parent might not ‘be there’ even whilst physically
present, as for this 15-year-old boy who in vain tried to
prevent his mother from injecting drugs by refusing to
leave the room. As his mother recounted:
“So in the end I did it in front of him whilst
he just sat there the tears rolling down his
face. I just said, ‘I’m sorry son, you know
mammy’s sick, you should have gone out
of the room, I had to do it.’”
Her son witnessed the mental separation that the drug
effected on his mother whilst looking helplessly on. 
3.22 Another powerful emotion described by many of the
children and young people was anxiety and fear for the
well-being of their parents. They knew from the media,
from others around them, and in some cases from
personal experience that drugs caused harm and even
death, as in this 12-year-old girl’s fretful description of her
father’s drug problem:
“And I went to a thing, it was in the SECC
and it was about drugs and it says heroin or
something’s the worst drug and it can kill
you and I started crying when I came home
‘cause I thought that he was gonnae die.“
3.23 This anxiety would lead to a watchful vigilance on
their parents that, as we have noted, in some cases
meant deliberately not going to school. This fear is
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obvious in the following account from a 15-year-old girl
who has lived with her now problem drug-using aunt
since the age of four, when both her parents died from
drug overdoses. 
“I was scared an’ that because, because I
realised that she was using that what my
real mum was using. An’ then I was scared
of losing her and I didnae want her to do it,
an’ I didnae want her to take it.”
Living with stigma and fear
3.24 The stigma that surrounds drug dependency
problems means that both parents and children are
reluctant to speak openly about the family secret for fear
of public censure and social isolation. Children and
parents alike share a fear that revealing a drug problem
will result in their separation through being taken into
care. This 12-year-old boy, for example, kept his mother’s
drug problem a secret out of fear of the consequences of
not doing so, including being mocked by his peers. 
“I just couldn’t tell anybody ‘cause it’s
like...it’s hard to tell someone and if they
find out, they like phone the police and you
might get took off your Mum and your Dad
and the Police will get involved and that.”
3.25 Children understood from an early age the
importance of keeping the family secret. As this
parent in the Liverpool consultation noted:
“Children have to keep the secret as
though they’re going to be punished.”
Many children were also ashamed of their parents’
problem, as this parent commented:
“They want to walk on the other side of
the road. They’re ashamed of you...they call
you ‘meth’, ‘tramp’.” 
3.26 To deflect attention away from the home, children
invented Christmas presents that were never received
and made up family outings that never happened. They
avoided letting people into the house and took care not
to refer to their parents. They also covered up for their
parents’ behaviour, including in some cases presenting
them as having an alcohol rather than a drug problem.
In their efforts to prevent ridicule and bullying from peers
or attention from outside agencies such as social
services, these young people were isolated and seldom
found an outlet for the expression of their experiences. 
Conclusion 
3.27 This chapter describes something of the experience
of family life in the context of parental drug problems
seen from the perspective of parents and, unusually,
children. What it shows is the all-pervasive nature of
problem drug use seeping into almost every aspect of
these children’s lives. Parents could and did try to control
their drug problem: some were successful, and their
children were not especially tainted by the problems so
often brought in the wake of uncontrolled use. However,
for many other parents their drug problem was less easy
to manage and could often be experienced as so
overwhelming that it was difficult to avoid it affecting
their children. As these parents and children so movingly
testify, drugs could and did have the capacity to deprive
children of many of the normal and valued aspects of
childhood. Listening to these voices underlines our
responsibility both to help parents find a way through
their drug problems and to find urgent means of
protecting and enabling children living in family
environments stressed by drugs.
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50 Hidden Harm – Responding to the needs of children of problem drug users 
Recommendations 
6. The voices of the children of problem drug users
should be heard and listened to.
7. Work is required to develop means of enabling
the children of problem drug users safely to express
their thoughts and feelings about their circumstances. 
